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ABSTRACT 
Anxiety is the most prevalent mental illness and treatments are effective but 
underutilized. Failure to design treatments that proactively reach individuals at varying 
levels of readiness may be one driver of under-utilization. The Transtheoretical Model 
of behavior change (TTM) offers a framework for designing treatments tailored to 
readiness to engage in exposure, the process of gradually approaching feared stimuli 
and the central behavioral component of evidence-based anxiety treatments. This 
study sought to develop the essential building blocks for applying the TTM to anxiety 
by developing a set of measures of core TTM constructs (Stage of Change, Decisional 
Balance, Self-efficacy, and Processes of Change) relevant for increasing approach 
behaviors in individuals with anxiety disorders.   
Measurement development entailed qualitative methods for item development and 
refinement followed by a series of quantitative analyses. The Stage of Change measure 
was validated against external constructs such as treatment seeking behavior, anxiety 
severity, and quality of life. As expected, a chi-square test indicated that individuals in 
Action and Maintenance were significantly more likely to be in treatment than those in 
the pre-Action stages. ANOVA results indicated that individuals in Action or 
Maintenance reported significantly lower levels of anxiety (F(1, 592) = 5.06, p=.025, 
η2=.01) and significantly higher quality of life (F(1, 592) = 8.20, p<.01, η2=.01) than 
those in pre-Action stages. 
Measures for Decisional Balance and Self-efficacy were developed using split-
half, cross-validation procedures. In these, a series of Principle Component Analyses 
(PCAs) were conducted with half of the sample to narrow the item set and explore 
  
 
factor structure, and Confirmatory Factor Analyses (CFA) was conducted on the 
second half of the sample to confirm factor structure and item loadings.  For 
Decisional Balance, PCA supported two, 5-item factors, and CFA indicated a two-
factor correlated model was the best fit to the data, χ²(35)=80.82, p<.01, CFI=.94, 
RMSEA =.7 with Pros α=.87 and Cons α=.75. For Self-efficacy, PCA supported one, 
6-item factor, and CFA further supported this structure, χ²(9)=30.39, p<.01, CFI=.98, 
RMSEA=.088, α=.90. Multivariate analyses indicated significant stage-construct 
relationships in expected directions with the exception of Cons, which showed no 
significant cross-Stage differences. 
For Processes of Change, a series of iterative CFAs were conducted to narrow the 
item set, and then additional CFAs were conducted on the final set of items to 
determine which factor structure was the best fit to the data. A 10-factor, fully 
correlated model was the best fit to the data, χ²(360)=905.82, p<.01, CFI=.94, RMSEA 
=.51. Factor loadings were strong, ranging from 0.53 to 0.85, and internal consistency 
was acceptable to good (α ranged from to .69 to .88).  Effect sizes for differences in 
POC across Stage were mostly in the medium range, indicating that POC represent 
important behavior change strategies for reducing anxiety-based avoidance.  
Overall results support the validity of the measures developed and laid the 
foundation for applying the TTM to anxiety-based avoidance. Implications for 
application of the TTM to anxiety-based avoidance are discussed. Future research 
should explore the relationship between these measures and treatment outcomes 
longitudinally and examine the effectiveness of TTM-tailored feedback in the context 
of a computer-based intervention.  
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PREFACE 
This dissertation was prepared in manuscript format. The three manuscripts 
contained therein have been written with the intention of submission to the following 
journals: Journal of Anxiety Disorders (Manuscript 1), American Journal of Health 
Promotion (Manuscript 2), and Journal of Nervous and Mental Disease (Manuscript 
3). The Appendix includes supplementary tables for the prepared manuscripts and 
discussion of additional analyses and findings that did not fit into the scope of the 
three primary manuscripts. 
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Abstract 
 
Anxiety is the most prevalent mental illness and treatments are effective but 
underutilized. Failure to design treatments that proactively reach individuals at varying 
levels of readiness may be one driver of under-utilization. The Transtheoretical Model 
of behavior change (TTM) offers a framework for designing treatments tailored to 
readiness to engage in exposure, a core behavioral component of anxiety treatment. 
The purpose of this study was to develop a measure of Stage of Change, the core TTM 
construct that defines readiness to change, relevant for anxiety-based avoidance. 
Online survey data were collected from 594 adults with clinically significant levels of 
anxiety. Survey data included measures of Stage of Change, anxiety severity, quality 
of life and current treatment status. Findings support the validity of the Stage of 
Change measure developed insofar as predicted relationships were observed between 
Stage and anxiety severity, quality of life and treatment status. 
 
Keywords 
Stages of Change, Anxiety, Exposure, Readiness, Transtheoretical Model 
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Anxiety is the most common form of mental health disorder, with lifetime 
prevalence estimates as high as a quarter of the general population.1 Anxiety is 
associated with significant impairments in educational and occupational functioning, 
worse physical health, and huge public health cost (ranging from $42 to $46 billion 
annually).2-5  
Cognitive-Behavioral treatments (CBTs) for anxiety are effective but 
underutilized. Effect sizes for CBTs for anxiety are large (d = 1.14 to 1.98)6,7 across 
treatment protocols and by definition, do not produce the same risk of side effects seen 
with pharmacological options. While protocols vary in a number of ways, exposure, or 
the process of systematically approaching feared stimuli in a progressively more 
emotionally challenging fashion, is a consistent part of CBTs for anxiety and arguably 
a cornerstone of these treatments. Dismantling studies have even found that exposure-
only therapies often perform as well as therapies with exposure plus additional 
cognitive components.8 9  
Unfortunately, only 4-11% of individuals with anxiety disorders receive any 
treatment.10 Of those who do receive treatment, the majority receive pharmacotherapy. 
Of those who receive psychotherapy, a minority are getting psychotherapy with CBT 
techniques like exposure.2,11 While much of the dissemination research to date has 
focused on increasing access, avoidance itself and perceived need are other prominent 
barriers to seeking treatment.10-12 These findings suggest a need to package exposure-
based treatments differently such that they can reach a wider segment of the 
population of individuals with anxiety disorders. 
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At least two steps are necessary to enhance the reach of exposure-based 
treatments for anxiety. First, empirically-supported interventions must be made more 
accessible so that they can reach a larger share of the population with anxiety 
disorders. Computerized interventions offer a low-cost treatment strategy, ideal for 
placement in widely used medical settings. Second, proactive approaches to treatment 
are needed to reach the segment of the population of individuals who are suffering 
from anxiety disorders, but not yet willing to make behavior changes necessary to 
manage their anxiety (i.e., address anxiety-based avoidance).  
The Transtheoretical Model of Behavior Change (TTM)13 provides a 
framework for developing interventions that could address issues related to both 
access and readiness to change key problematic behaviors like avoidance. The central 
organizing feature of the TTM is the five Stages of Change, which define an 
individual’s progress in preparing for and adopting new behavior patterns. The stages 
include three pre-Action stages: Precontemplation (not intending to make a change in 
the foreseeable future), Contemplation (intending to make a change in the next 6 
months), and Preparation (preparing to make a change in the next 30 days). There are 
two Action stages: Action (currently engaging in behavior change) and Maintenance 
(sustained behavior change for at least 6 months). Each stage of change is 
characterized in relation to a standard for the Action stage, which defines what is 
meant by successful change and therefore, is the driving characteristic of the staging 
algorithm.  
The TTM provides guidance on development of stage-matched interventions. 
These have most often been delivered as computer-tailored interventions or CTIs. 
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Such interventions are easy to access, cost-effective and applicable both to individuals 
ready to engage in change and those not yet ready. TTM-based CTIs have been used 
to intervene effectively on a wide array of behaviors from weight management to 
depression to domestic violence14-16 and may be a useful framework for 
conceptualizing and intervening on anxiety-based avoidance. 
To date, applications of the TTM to anxiety have been limited. In particular, no 
anxiety-specific staging algorithm has been developed. Several studies have utilized 
the University of Rhode Island Change Assessment (URICA)17 Stage of Change 
measure as a predictor of treatment outcomes in pharmacotherapy as well as of 
engagement and outcomes in psychotherapy.18-20 While the URICA offers a strong 
measure of readiness in some contexts, it poses two core problems. First, difficulty of 
scoring and interpretation are a barrier to use. Second, the URICA leaves the target of 
change vague, and evaluations of staging algorithms for other types of behavior 
change indicate using a specific definition for the target of change is optimal.21 
The purpose of this study was to develop and assess preliminary validity of a 
Stage of Change algorithm for reducing anxiety-based avoidance – the primary 
behavioral target of evidence-based treatments for anxiety. Measures of anxiety 
severity, quality of life, and treatment seeking behavior were evaluated in relation to 
Stage to examine the validity the Action criterion used to define this measure of Stage 
of Change. A wealth of literature on empirically supported behavioral treatments for 
anxiety has established a link between approach behaviors and anxiety 
reduction/improved quality of life. It was, therefore, hypothesized that individuals in 
Action and Maintenance (i.e., those who were regularly challenging themselves to 
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approach anxiety-producing stimuli in their environments) would report lower 
symptoms and impairment from anxiety and better quality of life. Additionally, we 
hypothesized that those in Action and Maintenance would be more likely to report 
being in treatment for their anxiety, as approach behaviors are a primary target of 
psychotherapy for anxiety and medications have been found to reduce symptoms of 
anxiety, such as avoidance. 
1. Method 
1.1 Participants 
1.1.1 Recruitment 
Participants needed to meet two eligibility criteria to participate in the study: 
they needed to be over the age of 18 and to score an 8 or higher on the Overall 
Anxiety Severity and Impairment Scale (OASIS), which has been found to indicate 
clinically significant anxiety.22 Prior to conducting online survey data collection, 
qualitative interviews were conducted with a small set of participants (n=10) to 
evaluate clarity and face validity of the staging algorithm. Qualitative interview 
participants were recruited through flyers placed at community centers, mental health 
treatment centers, and universities. Flyers asked that interested participants call the 
primary investigator, at which point they were consented to engage in a screening 
questionnaire for eligibility (age and OASIS score). Twenty individuals called to 
inquire about participation. Thirteen of these individuals were eligible to participate, 
and ten chose to participate in qualitative interviews. Participants in the qualitative 
interviews were reimbursed $20 for their participation.  
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The sample for the online survey portion of the study was recruited through 
Survey Sampling International (SSI), an online survey sampling company. Toward the 
end of survey data collection, additional eligibility criteria—only non-white 
participants (25 completes) and only pre-Action Stage of Change (128 completes)—
were included for the remaining recruitment process in order to ensure an adequately 
diverse sample. All recruitment and human subjects procedures were approved by the 
University of Rhode Island’s institutional review board. 
1.1.2 Sample Characteristics 
Ten individuals participated in qualitative interviews. The average age was 
36.6 and the average OASIS score was 11.3. Three of the qualitative interview 
participants were recruited from a local mental health treatment center, four were 
recruited from a community support center, and three were recruited from the 
University of Rhode Island community. Seven of the qualitative interview participants 
were male and three were non-white. 
SSI recruited 594 eligible adults to participate in the online survey portion of 
this study (sample demographics are summarized in Table 1). The sample was 
primarily female (69.4%, n=412), and ages ranged from 18 to 80 (M = 38.6, SD = 
13.8). The majority of the sample was white (n=454, 76.4%), 12.8% were Black 
(n=76), 3.7% were Asian (n=22), and 7.1% classified themselves as not fitting any of 
these racial categories (n=42). Of the 594 participants, 14.1% were in 
Precontemplation (n=84), 3.9% were in Contemplation (n=23), 20.7% were in 
Preparation (n=123), 17.0% were in Action (n=101), and 44.3% were in Maintenance 
(n=263). Self-reported diagnoses were as follows: Panic Disorder 44.9% (n=267), 
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Agoraphobia 11.8% (n=70), Obsessive Compulsive Disorder 25.6% (n=152), Post-
traumatic Stress Disorder 19.9% (n=118), Social Anxiety Disorder 45.1% (n=268), 
Generalized Anxiety Disorder 52.5% (n=312), Specific Phobia 12.1% (n=72), Anxiety 
Not Otherwise Specified 13.8% (n=82), diagnosed with “anxiety” but not specific 
disorder 4.2% (n=25), never diagnosed with an anxiety disorder 5.2% (n=31). 
Diagnoses were self-reported and individuals were asked to select all diagnoses that 
they had been given so diagnostic categories reported are not mutually exclusive. 
1.2 Measures 
 In addition to the measures described below, the survey administered included 
measures of demographic characteristics, self-reported anxiety diagnoses and current 
treatment status. In terms of treatment status, individuals were asked to select one of 
the following treatment status categories: (a) I am NOT currently in treatment for 
anxiety; (b) I currently take medication for anxiety (prescribed by a health 
professional like a doctor, nurse or psychiatrist); (c) I currently go to therapy or 
counseling for anxiety (meeting for 30 minutes to an hour to discuss your feelings 
with a professional); (d) I currently take medication and go to therapy for anxiety.  
1.2.1 Overall Anxiety Severity and Impairment Scale (OASIS)23 
 The OASIS was used to determine eligibility for participation. The OASIS is a 
5-item self-report measure that evaluates the severity of and impairment associated 
with an anxiety disorder. Participants rate the degree to which each item describes 
them over the past week on a 5-point scale ranging from 0 (None) to 4 (Extreme/All 
the Time). A sum score of 8 or greater has been found to accurately classify 87% of 
individuals as having an anxiety diagnosis.22 This scale was selected because of its 
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strong psychometric properties, adequate coverage of symptoms relevant for all 
anxiety diagnoses, and ease of use (i.e., short length, free access, and easy scoring).  
1.2.2. Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (QLSE-
Q-SF)24 
 The Q-LES-Q-SF is designed to assess the level of enjoyment and satisfaction 
individuals experience in activities of daily functioning. It is comprised of 14 items 
evaluating satisfaction in a number of realms and two additional overall life 
satisfaction items that are not included in the score for the measure. Participants rate 
items on a 5-point scale ranging from 1 (Very Poor) to 5 (Very Good). A summary 
score is calculated for the first 14-items and then converted to a proportion of the 
maximum possible score. Higher proportions, therefore, indicate greater satisfaction 
with life. This scale shows strong reliability and validity and, in particular, has shown 
adequate sensitivity to the severity of anxiety.25,26  
1.2.3. Stage of Change 
Participants were asked to answer a series of questions about whether they 
regularly challenge their tendency to avoid anxiety-producing stimuli (see appendix 
for a printed copy of the measure). Questions placed participants in one of five 
mutually exclusive Stage of Change categories based on their answers to a series of 
Yes/No questions (see appendix for Stage of Change Measure). The behavioral target 
or criterion for assigning an individual to the Action stage, was defined as “at least 
once a week, you push yourself to approach some of the things that you often avoid 
(or choose not to do) because of anxiety.” This criterion was based on evidence that 
exposure to feared stimuli reduces symptoms of anxiety and impairment from anxiety. 
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For pre-action stages, participants were assigned to: Precontemplation if they indicated 
that they were not currently approaching feared stimuli regularly and did not intend to 
do so in the next six months; Contemplation if they were not currently approaching 
feared stimuli regularly, but intended to begin doing so in the next six months; and 
Preparation if they were not currently approaching feared stimuli regularly, but 
intended to begin doing so in the next 30 days. Participants were assigned to Action if 
they reported currently meeting the Action criterion and were assigned to Maintenance 
if they reported having been engaged in this behavior for at least six months. 
1.3 Data Analysis 
ANOVA was used to determine whether individuals in the 
Action/Maintenance stages of change showed different levels of anxiety severity and 
quality of life than those in pre-Action stages. A chi-square test was used to evaluate 
whether there was a significant association between participants’ treatment status (in 
treatment versus not in treatment) and being in a pre-Action versus 
Action/Maintenance Stage of Change. 
2. Results 
 
2.1.1 Descriptive Results 
 In terms of current anxiety treatment, 30.6% (n=182) were not currently in any 
treatment, 41.3% (n=256) were taking medication only, 9.1% (n=54) were in 
psychotherapy only, and 17.1% (n=102) were taking medication and going to 
psychotherapy. Among the individuals who reported that they were in psychotherapy, 
92.3% (n=144) reported that their therapist had encouraged them to engage in 
exposure exercises.   
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2.1.2 External Validity of SOC Action Criterion 
To test validity of the Action criterion as a basis for measuring Stage of 
Change, differences in anxiety levels (OASIS score) and quality of life (QLESQ-SF 
score) among individuals in pre-Action versus the Action/Maintenance Stages of 
Change were evaluated using ANOVA. A significant difference was observed in 
OASIS scores between those in pre-Action stages versus Action/Maintenance (F (1, 
592) = 5.06, p = .025, η2=.01). Individuals in Action or Maintenance (M = 12.01, SD 
= 3.20) reported significantly lower levels of anxiety than individuals in the pre-
Action stages (M = 12.60, SD = 3.06). A significant difference was also observed in 
QLESQ-SF scores between those in pre-Action versus Action or Maintenance (F (1, 
592) = 8.20, p < .01, η2=.01). Individuals in Action or Maintenance (M = 0.47, SD = 
0.19) reported significantly higher quality of life than individuals in the pre-Action 
stages (M = 0.43, SD = 0.18).  
A chi-square test evaluating the relationship between Stage (pre-Action versus 
Action/Maintenance) and current treatment status was significant, thereby supporting 
an association (χ2(1, n=594) = 10.26, p<.01, phi=.13). Participants reporting that they 
were currently engaging in approach behaviors on a regular basis (i.e., Action or 
Maintenance stages) were more likely to be in treatment than not in treatment (see 
Table 1 in appendix).  
3. Discussion 
 The primary purpose of this study was to develop and evaluate the preliminary 
validity of a Stage of Change algorithm for reducing anxiety-based avoidance. To our 
knowledge, no other study to date has built and validated a staging algorithm for 
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application to anxiety disorders. The URICA staging algorithm, has been used in 
anxiety research, but this measure is difficult to score and interpret and is not best 
practice when applying the TTM to a new behavior because the target of change is not 
specified. Accurate assessment is key to developing population-based interventions 
tailored to readiness to engage in behavior change. 
Results supported the validity of the Action criterion used—at least once a 
week, you push yourself to approach some of the things that you often avoid (or 
choose not to do) because of anxiety. Reports of accomplishing this behavioral goal 
were associated with lower levels of anxiety and impairment (OASIS scores), better 
reported quality of life (QLESQ-SF scores) and higher rates of treatment seeking. 
Thus, this study provides preliminary support for the developed measure of Stage of 
Change to engage in approach behaviors. 
 This study had several limitations. First, the sample consisted of individuals 
who expressed an interest in online survey research participation, which may have 
introduced some sample bias. Future studies could evaluate findings in samples 
collected via proactive recruitment in a community or medical settings. Second, the 
sample, while nearly representative of national racial demographics, was primarily 
white and female. This may limit the generalizability of findings. Third, all data were 
self-reported, and there was wide variation in the length of time it took individuals to 
complete the survey. As with most research that relies on self-report, these factors 
raise the possibility of random and careless responding. Fourth, test-retest data was not 
available in this dataset, but would be useful for further, future validation. Fifth, the 
definition of Stage of Change may have provided enough information to some 
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participants to make them more likely to consider change and, therefore, indicate that 
they were in later Stage of Change (i.e., not Precontemplation). Finally, the ideal 
external criteria for validation of the Stage of Change tool developed would have been 
a behavioral measure of engagement in self- or therapy-directed exposure. 
Unfortunately no such previously validated measure exists that cuts across anxiety 
diagnoses. However future research could evaluate the relationship between stage and 
clinician report of exposure exercise engagement or previously validated behavioral 
measures of engagement in exposure designed for use in a specific diagnostic 
subsample (e.g., the Liebowitz Social Anxiety Scale27 for individuals with social 
anxiety disorder).  
Nevertheless, this study has a number of strengths and will help guide future 
investigation. It describes the development and initial validity findings for a Stage of 
Change algorithm specific to anxiety treatment. This measure can be used in future 
research to evaluate the impact that readiness has on treatment outcomes. It may also 
be used in clinical work to inform intervention strategies (e.g., more motivational 
session content versus more action-oriented session content). Finally, it may be used 
in the context of intervention development to create scalable treatments that are 
tailored to individuals’ readiness to change patterns of avoidance. 
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Table 1. 
Sample Characteristics 
Variable      Participants 
Sex      
    Male      30.6% (n=182) 
    Female      69.4% (n=412) 
Race    
    White      76.4% (n=454)     
    Black      12.8% (n=76) 
    Asian        3.7% (n=22) 
    Other        7.1% (n=42) 
Stage of Change for anxiety management 
    Precontemplation     14.1% (n=84) 
    Contemplation       3.9% (n=23) 
    Preparation      20.7% (n=123) 
    Action      17.0% (n=101) 
    Maintenance     44.3% (n=263) 
Self-reported diagnoses (not mutually exclusive) 
    Panic Disorder (with or without Agoraphobia) 44.9% (n=267) 
    Agoraphobia (with or without Panic)  11.8% (n=70) 
    Obsessive Compulsive Disorder   25.6% (n=152) 
    Post-traumatic Stress Disorder   19.9% (n=118) 
    Social Anxiety Disorder    45.1% (n=268) 
    Generalized Anxiety disorder   52.5% (n=312) 
    Specific Phobia     12.1% (n=72) 
    Anxiety NOS     13.8% (n=82) 
    Diagnosed with Anxiety, but no specific disorder   4.2% (n=25) 
    Never diagnosed with and anxiety disorder   5.2% (n=31) 
Treatment status (mutually exclusive categories) 
    No treatment     30.6% (n=182) 
    Medication only     43.1% (n=256) 
    Therapy only       9.1% (n=54) 
    Combined (medication and therapy)  17.2% (n=102) 
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Appendix (to be included in manuscript submission) 
Stage of Change Measure for Reducing Anxiety-Based Avoidance 
Anxiety is not just feeling “stressed” or “nervous.” Anxiety is when stress or 
nervousness interfere with your daily life. People who are anxious may:  
 Avoid events, activities, places or things that make them anxious  
 Have unpleasant physical feelings like racing heart, dizziness and/or upset 
stomach  
 Experience upsetting thoughts that seem to take over their minds such as  
o Worries (e.g., “what if” questions)  
o Concerns about some specific thing like getting sick or dirty  
o Thoughts about a traumatic past event like abuse or a car accident  
 
At least one in four people experience anxiety at some point in their lives. 
For example, managing your anxiety may mean  
 Committing to do things that are important to you (e.g., look for a new job or 
go on a date) even if worry or anxiety makes you not want to do those things. 
 Pushing yourself to speak up at a meeting or give a speech to an audience.  
 Doing light exercise even if this is a trigger for panic attacks.  
 Touching things others are ok with touching, but that you often see as dirty.  
 Leaving your house if you become anxious when you are far away from home. 
 Getting on a plane if you are nervous when flying. 
 Allowing yourself to experience thoughts about a past trauma. 
 
 20 
 
Even though doing these things can make you feel more anxious at first, research 
shows that doing them actually makes you LESS anxious over the long term.  
 
Q1: Do you currently, at least once a week, push yourself to approach things that you 
often avoid (or choose not to do) because of anxiety?  
__Yes (if YES, please skip to Question 4) 
__No (if NO, continue to next question) 
 
Q2: In the next 6 months, do you intend to start managing your anxiety by, at least 
once a week, pushing yourself to approach things that you often avoid (or choose not 
to do) because of anxiety?  
__Yes (if YES, continue to next question) 
__No (if NO, this questionnaire is complete) 
 
Q3: In the next 30 days, do you intend to start managing your anxiety by, at least once 
a week, pushing yourself to approach things that you often avoid (or choose not to do) 
because of anxiety? 
__Yes (You are done. This questionnaire is complete.) 
__No (You are done. This questionnaire is complete.) 
 
Q4: (Only answer if you answered ‘YES’ to Question 1) For how long have you been 
managing your anxiety by, at least once a week, pushing yourself to approach things 
you would often avoid (or choose not to do) because of anxiety? 
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__Less than 6 months (You are done. This questionnaire is complete.) 
__More than 6 months (You are done. This questionnaire is complete.) 
 
Scoring:  
-Precontemplation – NO to Question 1 and NO to Question 2 
-Contemplation – NO to Question 1 and YES to Question 2 and NO to Question 3 
-Preparation – NO to Question 1 and YES to Question 2 and YES to Question 3 
-Action – YES to Question 1 and NO to Question 4 
-Maintenance - YES to Question 1 and YES to Question 4 
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Abstract 
 
Purpose. Anxiety is the most common and costly mental illness in the United States. 
Avoidance is the cornerstone of anxiety, and reducing the incidence of avoidance is a 
core element of evidence-based treatments. Investigating anxiety-based avoidance 
from a Transtheoretical Model (TTM) perspective could facilitate development of 
interventions applicable for both individuals ready and not yet ready to address their 
anxiety. This study validated TTM measures of Decisional Balance and Self-efficacy 
for reducing anxiety-based avoidance. 
Design. Cross sectional measurement development.  
Setting. Qualitative interview and online survey. 
Subjects. 604 individuals, ages 18-70 with clinically significant anxiety.  
Measures. Stages of Change, Decisional Balance, and Self-efficacy. 
Analysis. The sample was randomly split into halves for exploratory principal 
components analysis (PCA), followed by confirmatory factor analyses (CFA) to test 
measurement models. Multivariate analyses examined relationships between 
constructs. 
Results. For Decisional Balance, PCA indicated two, 5-item factors (Pros α=0.85; and 
Cons α=0.67). CFA supported a two-factor correlated model, χ²(35)=80.82, p<.01, 
CFI=.94, RMSEA =.7 with Pros α=.87 and Cons α=.75. For Self-efficacy, PCA 
indicated one 6-item factor (α=0.87). CFA supported this structure, χ²(9)=30.39, 
p<.01, CFI=.98, RMSEA=.088, α=.90. Multivariate analyses indicated significant 
cross-stage differences for Pros and Self-efficacy in expected directions. 
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Conclusion. Findings support internal and external validity of these measures. Stage-
construct relationships suggest Cons for reducing avoidance may be more stable 
across stages than Cons for other behavior changes. These measures may be used to 
develop a computer-tailored intervention for anxiety. 
Key Words: anxiety, Transtheoretical Model, Decisional Balance, Self-efficacy, 
exposure therapy, Stages of Change 
Indexing Key Words: Manuscript format: research; Research Purpose: instrument 
development/validation; Study Design: Cross-Sectional; Outcome measure: 
behavioral; Setting: population-based; Health focus: medical self-care; Strategy: skill 
building/behavior change; Target population age: adults; Target population 
circumstances: survey company database. 
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PURPOSE 
 Anxiety is the most prevalent form of mental illness in the United States. It is 
estimated that at least one in four people develop an anxiety disorder at some point 
during his or her life.1 Compared with the general population, individuals with anxiety 
disorders experience lower quality of life,2,3 educational and occupational 
impairment,4-8 as well as increased risk of comorbid medical problems4,9,10 and 
suicide.11,12 In addition to personal costs, anxiety disorders have a large public health 
cost, accounting for about one third of total expenditures on mental illness. The annual 
cost of anxiety disorders in the US is estimated to be between $42 and $46 billion 
dollars.13-15 
Research on the efficacy of cognitive-behavioral treatments (CBTs) for anxiety 
shows consistently large effect sizes (d = 1.14 to 1.9816) and suggests 50%-80% of 
patients attain clinically significant effects.17 The primary behavioral component of 
evidence-based treatments for anxiety is exposure exercises, in which patients practice 
facing anxiety-provoking stimuli that are progressively more emotionally 
challenging.18 For example, a patient with social anxiety may complete exposure 
exercises that involve a set of social activities ranging from less anxiety-provoking 
(e.g., asking a close friend if he/she is interested in getting together informally) to 
more anxiety-provoking (e.g., asking someone out on a date). This treatment strategy 
is based on classic behavioral studies of extinction of feared responses.19-21 
Research suggests that exposure exercises are key to overcoming anxiety. A 
number of dismantling studies aimed at determining the active components of 
evidence-based treatments for anxiety indicate that the cognitive elements of 
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evidence-based therapies for anxiety do not significantly increase the efficacy of 
exposure therapy. For example, exposure-only treatments have been found to be as 
effective as treatments with exposure and cognitive components in treatment of social 
anxiety disorder and posttraumatic stress disorder.22-26 Similarly, meta-analyses 
suggest that exposure-only treatments perform equivalently to exposure plus cognitive 
treatments for Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic 
Disorder, and Social Phobia.27-32  
Unfortunately, most individuals with anxiety disorders do not receive exposure-
based therapy. It is estimated that as few as 4-11% of individuals with anxiety 
disorders seek mental health treatment at all.33,34 Research suggests that the main 
reasons for not getting treatment are: poor access (encountering logistical barriers such 
as cost and availability) and intra-individual variables that affect readiness (not being 
receptive to treatment or not believing one’s symptoms warrant treatment).35 In 
support of the importance of intra-individual variables, studies have found that many 
people with access to trained exposure therapy practitioners do not initiate or stay in 
treatment. Pre-treatment attrition among patients diagnosed with anxiety disorders and 
offered free therapy is 30-52%.36-38 Dropout rates among those seeking treatment are 
estimated to be as high as 31%.38 Intra-individual barriers are particularly relevant in 
exposure therapy because approaching feared stimuli is not an intuitive or comfortable 
way to address anxiety.39  
A Computer-Tailored Intervention for Anxiety 
A population-based approach to anxiety disorders is needed in order to improve 
the massive public health toll of this treatable mental illness. Such an approach would 
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need to involve efforts to improve access to treatment and address intra-individual 
variables that affect readiness to address one’s anxiety. To date, dissemination efforts 
have focused on increasing access (e.g., training more providers, providing group 
treatment, making treatments available in non-specialty settings39,40) rather than 
reducing intra-individual barriers. A readiness-focused, Computer-Tailored 
Intervention (CTI) would address both access and intra-individual barriers.  
CTIs are optimal for improving reach since they are easy to access, inexpensive to 
distribute, and have a strong history of effectively incorporating readiness-based 
information using the Transtheoretical Model of behavior change (TTM). Such an 
intervention could be used as a primary treatment for individuals without access to or 
not yet ready for in-person treatment. It could also be a complement to in-person 
treatment aimed at encouraging individuals with clinically significant anxiety to 
engage exposure exercises or to gradually begin approaching feared stimuli.  
The Transtheoretical Model Of Behavior Change (TTM) 
The TTM provides an evidence-based framework for organizing CTIs that help 
motivate individuals to engage in new behaviors.41 Numerous randomized controlled 
trials support the effectiveness of computerized, TTM-tailored interventions targeting 
a variety of behavioral and mental health issues such as exercise adoption, depression 
management and domestic violence cessation.42-44 The TTM’s readiness-based 
approach to behavior change is consistent with recent evidence that readiness-based 
therapy techniques, such as Motivational Interviewing, enhance the efficacy of CBT 
for anxiety when applied as a pre-treatment.45,46 The TTM is particularly powerful as a 
theoretical basis for such an intervention because it provides empirically-based 
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guidance on which intervention strategies work best in each stage, and hence 
systematically meets patients where they are in terms of readiness. 
The TTM posits that initiating new behavior patterns involves progressing through 
a series of five Stages of Change: Precontemplation (not yet intending to take action), 
Contemplation (intending to take action in the near future, but not immediately), 
Preparation (taking steps necessary for action), Action (initiating the new behavior 
pattern) and Maintenance (>6 months of successful action). Action is defined with 
respect to the behavioral target: in the case of this study, action is readiness to engage 
in exposure exercises. 
According to the TTM, readiness to change is largely based on the relative weights 
of the pros (advantages of change) compared with the cons (disadvantages of 
change).47 A stable pattern of Decisional Balance across Stages of Change has been 
observed across over 48 different health behaviors.48 In the Precontemplation Stages 
of Change, the Cons outweigh the Pros. The relative weight of Pros and Cons reverses 
between the Contemplation and Preparation stages, such that Pros become more 
important and Cons less important.49 This pattern of change in Decisional Balance is 
hypothesized to be an essential driver of progress toward Action and Maintenance. 
In addition to Decisional Balance, the TTM focuses on Self-efficacy as an 
important factor in an individual’s readiness to change. Self-efficacy is defined as 
one’s level of confidence in one’s ability to successfully change a target behavior 
across a variety of challenging situations.50 Research indicates that Self-efficacy 
scores are higher in the later Stages of Change. The largest differences in Self-efficacy 
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have been observed in comparisons of individuals in the Action Stage of Change with 
those in the earliest Stages of Change.50,51  
Goals of the Current Study 
Given the serious health effects of anxiety disorders and the low rate of 
utilization of evidence-based interventions, alternative models of treatment are needed. 
Research indicates that the exposure process, that is the gradual confrontation of 
feared internal, external and imagined stimuli, is an effective way to reduce the 
severity of anxiety and impairment from anxiety. The aim of the current study is to 
develop and validate measures of Decisional Balance and Self-efficacy for adults with 
clinically significant levels of anxiety. This is an essential step toward the 
development of a TTM-directed CTI for anxiety. 
Although some research on anxiety has utilized generic Stages of Change 
measures,52 no study has yet evaluated core TTM constructs that drive change such as 
Decisional Balance and Self-efficacy. This study, therefore, builds upon existing 
literature by developing and evaluating measures expected to be useful in increasing 
self- or therapist-directed engagement in exposures for anxiety. This study also seeks 
to evaluate the potential usefulness of an application of the TTM to anxiety-based 
avoidance. Its findings could have a substantial impact on the way that treatment is 
conceptualized and eventually delivered. 
METHODS 
Design 
 This study used a sequential process of measurement development to develop 
of measures of two key TTM constructs—Decisional Balance and Self-efficacy.54-56 
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Items were developed via a series of semi-structured expert and participant interviews. 
Item development was followed by exploratory, confirmatory and external validation 
quantitative analyses.  
Item Development 
 Items were initially developed based on a comprehensive review of TTM 
measures for other behaviors and conclusions from the literature on reasons 
individuals tend to persist in avoiding things that make them anxious and on barriers 
to changing avoidance patterns.  
Expert Interviews 
After this initial development, items were further refined using feedback from 
experts in anxiety disorders and the TTM. Two, PhD- level experts in anxiety 
disorders were engaged in semi-structured interviews in which they provided feedback 
on the proposed set of items. Additionally, three experts in the TTM were asked to 
review the proposed set of items for clarity and adherence to the theoretical 
foundations of the constructs.   
Qualitative Participant Interviews 
Once feedback from experts was incorporated, 10 structured qualitative 
interviews with anxious adults recruited from the community were conducted. The 
goal of the qualitative interviews was to elicit participant feedback on item clarity, 
acceptability, and face validity.  In order to be eligible for participation in qualitative 
interviews, individuals had to be over 18 and had to receive a score of 8 or above on 
the Overall Anxiety Severity Questionnaire (OASIS).57  Qualitative interviews were 
conducted in a private room in a location convenient for the participants (i.e., 
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community library, university office, or the mental health clinic from which they were 
recruited). When participants arrived, they were presented with an informed consent 
form, it was explained orally, and they were then given the opportunity to review the 
written copy on their own before signing. No participants withdrew from the study 
after reviewing informed consent form. Participants then completed a survey and 
provided oral feedback in an interview format. Consistently problematic items were 
discussed by the research team and eliminated or modified. 
Survey Administration 
 The survey was administered using FluidSurveysTM online survey software. 
Participants accessed the survey via an online link, which took them to the informed 
consent page. Individuals were asked to check a box indicating that they had read the 
informed consent form and agreed to participate. They were then routed to questions 
on eligibility criteria (which were the same as those for the qualitative interviews), on 
age and on level of anxiety per the OASIS. Eligible individuals were then linked to the 
full survey. Data were extracted from FluidSurveysTM into SPSS for exploratory and 
external validation analyses and EQS for confirmatory analyses. 
Sample 
Recruitment  
Participants for qualitative interviews were recruited through flyers placed at 
universities, community centers, and mental health treatment centers. Interested 
participants were asked to call the primary investigator to get more information. When 
participants called, they were presented with an informed consent form to engage in a 
screening questionnaire, which included the OASIS.57 Individuals with sufficiently 
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high levels of anxiety per the OASIS (>8) were given the option to participate. Twenty 
individuals called expressing interest in participating and 13 of these individuals were 
eligible. Of the thirteen individuals three had difficulty scheduling a time to participate 
and 10 participated. Qualitative interview participants were reimbursed $20 for their 
participation.  
Participants for the online survey administration phase of the study were 
recruited through Survey Sampling International. Eligibility criteria were added during 
recruitment to ensure adequate representation across certain groups. Additional 
eligibility criteria were included as follows: only non-white participants (25 
completes) and only pre-Action Stages of Change (128 completes). All recruitment 
and human subjects procedures were approved by the University of Rhode Island’s 
Institutional Review Board. 
Qualitative Interview Sample 
 Ten, one-on-one qualitative interviews were conducted by a doctoral student 
with eligible and interested individuals. The average age of cognitive interview 
participants was 36.6 and the average OASIS score was 11.3. Three of the qualitative 
interview participants were recruited form a local mental health treatment center, four 
were recruited from a community support center, and three were recruited from the 
University of Rhode Island community. Seven of the qualitative interview participants 
were male and three were non-white.  
Survey Sample 
 A sample of N=594 individuals between the ages of 18 and 80 (M=38.62, 
SD=13.84) were recruited via Survey Sampling International (SSI). The majority of 
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the sample was white (n=454, 76.4%), 12.8% were Black (n=76), 3.7% Asian (n=22), 
and 7.1% classified themselves as not fitting into these racial categories (n=42). Of the 
594 participants, 14.1% were in Precontemplation (n=84), 3.9% were in 
Contemplation (n=23), 20.7% were in Preparation (n=123), 17.0% were in Action 
(n=101) and 44.3% were in Maintenance (n=263). The majority of the sample was in 
some form of treatment for their anxiety (69.4%, n=412). 43.1% of the sample was 
taking medication without therapy (n=256), 9.1% was in therapy only (n=54), and 
17.2% was taking medication and was in therapy (n=102). 
Measures 
Measures Used 
Overall Anxiety Severity and Impairment Scale (OASIS).58 The OASIS was 
used to determine eligibility to participate. The OASIS is a 5-item self-report measure 
that evaluates severity and impairment associated with any anxiety disorder. 
Participants rate the degree to which each item describes himself or herself over the 
past week on a 5-point scale ranging from 0 (None) to 4 (Extreme/All the Time). A 
score of 8 or greater has been found to accurately classify 87% of individuals as 
having an anxiety diagnosis.57 This scale was selected based on strong psychometric 
properties, adequate coverage of symptoms relevant for all anxiety diagnoses, and ease 
of use (i.e., short length, free access, and easy scoring). Good internal (α=0.80) and 
one-month test-retest reliability (κ = 0.82) have been reported. Research shows strong 
convergent validity with other measures of anxiety.58  
Measures Developed 
 34 
 
Stage of Change. Participants were asked to answer a series of questions about 
whether they regularly (at least once a week) approach things they would usually 
avoid because of anxiety. These questions placed participants in one of five mutually 
exclusive Stages of Change categories. The Action criterion, which was phrased 
“managing your anxiety,” was defined as “at least once a week, you push yourself to 
approach some of the things that you often avoid (or choose not to do) because of 
anxiety.” This action criterion was based on the evidence that exposure to feared 
stimuli reduces anxiety and impairment. 
  Participants were assigned to a Stage of Change category based on their 
answers relative to the Action criterion. They were put in the Precontemplation stage 
if they indicated that they were not currently approaching feared stimuli regularly and 
did not intend to do so in the next six months; to Contemplation if they intended to 
begin doing so in the next six months; and to Preparation if they intended to begin 
doing so in the next 30 days. Participants were assigned to the Action stage if they 
were currently approaching feared stimuli regularly, but had been doing so for less 
than six months, and to Maintenance if they had been doing so for six months or 
longer. 
Decisional Balance. Twenty items were used to create the Decisional Balance 
scale. Ten items represented the Pros of approaching feared stimuli regularly and ten 
reflected the Cons of approaching feared stimuli regularly. Respondents were asked to 
indicate how important each item was in their decision of whether to change 
avoidance patterns on a 5-point Likert scale ranging from 1 = ‘Not Important at All’ to 
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5= ‘Extremely Important.’ The score for this scale was the sum of participant’s 
responses. 
Self-efficacy. Ten items were used to develop the Self-efficacy scale. Items 
evaluated participants’ confidence in their ability to approach feared stimuli regularly 
in a variety of challenging situations (e.g., when their schedules become busy). 
Participants indicated their confidence levels on a 5-point Likert scale, ranging from 1 
= “Not at All Confident” to 5 = “Extremely Confident. The total score for this scale 
consisted of the sum of the participant’s responses. 
Analysis 
 Three phases of analyses were conducted: exploratory, confirmatory, and 
external validation. The sample was randomly split such that one half could be used 
for the Principal Components Analyses (PCAs, n=289). PCAs were conducted to 
determine the number of components and reduce scales to a smaller set of items. Item 
selection was an iterative process that involved removing items for quantitative 
reasons (loadings <.40, correlations >.70 with other items, or high loadings on 
multiple factors) and qualitative reasons (to avoid redundancy and maintain the 
conceptual breadth of construct). In the second phase of analysis, Confirmatory Factor 
Analyses (CFAs) were conducted using the second half of the sample (n=305).  CFAs 
were used to evaluate the degree to which an independent portion of the data fit the 
model created by iterative PCAs. Model fit and factor loadings were evaluated. 
Finally, external validation analyses were conducted with the full sample (N=594). In 
this phase, MANOVA was used to evaluate the relationships between Decisional 
Balance factors and Stage of Change. ANOVA was used to evaluate the relationship 
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between Self-efficacy and Stage of Change.  Relationships were evaluated for 
consistency with patterns seen for other health behaviors.48 Linear regressions were 
also conducted to evaluate whether predicted relationships between TTM constructs 
and severity of anxiety were observed.  
RESULTS 
Exploratory Analyses 
 Exploratory procedures included PCA with varimax rotation. Sample size 
(n=289) was adequate based on existing literature.59,60. Decisions regarding retention 
of components were based on parallel analysis61 and minimum average partial 
procedures (MAP),62 both of which have been found to be accurate methods.63  
Exploratory analyses were used to determine the number of components, the 
correlations between components, and the loadings of items on these components. 
Items with poor (<.40) and complex loadings (>.40 on more than one factor) were 
removed. In later steps of exploratory analyses, items that had content that overlapped 
with items that had higher loadings were also removed. 
Decisional Balance 
 The initial PCA included twenty Decisional Balance items. In total, five PCAs 
were conducted. These reduced the measures to 10 items equally representing the Pros 
and Cons of regularly approaching feared stimuli. MAP and parallel analysis 
supported a two-component solution. Final item loadings ranged from .53 to .83. 
Internal consistency was good for the 5-item Pros scale (α = .86) and adequate for the 
5-item Cons scale (α = .67). Together the two factors accounted for 53.96% of the 
total item variance. 
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Self-efficacy 
 The initial PCAs included ten Self-efficacy items. Four PCAs were conducted, 
which reduced the original ten items to six. MAP and parallel analysis supported a 
single component solution. Item loadings ranged from .76 to .83. The final set of six 
items had good internal consistency (α = .87) and accounted for 62.67% of the total 
item variance. 
Confirmatory Analyses 
Confirmatory factor analyses were conducted with the structural equation 
modeling software EQS using the remaining subsample (n=305).64 Sample size was 
adequate based on existing literature.59 Robust estimation methods were used for fit 
indices since item data was ordinal.59 The fit indices calculated were the Satorra-
Bentler scaled chi-square, the comparative fit index (CFI), and the absolute 
standardized residual statistic (AASR). Traditionally, CFI values of 0.90 and above 
are considered to indicate good fit.65 RMSEA values between .05 and .08 suggest 
reasonable error of approximation and values >1 indicate poor fit.66  
Decisional Balance 
 The following measurement models were compared for the ten-item Decisional 
Balance measure: (1) a null model that supported ten independent variables and no 
latent factors; (2) a two-factor uncorrelated model; and (3) a two-factor correlated 
model. Fit indices for each model are summarized in Table 1. 
 The two-factor correlated model showed the best fit to the data. Factor 
loadings ranged from .49 to .83. Fit indices suggested strong model fit, χ²(34)=68.23, 
p<.01, CFI=.95, RMSEA =.06. The correlation between the two scales was r=0.28 and 
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coefficient alphas were good for Pros (α = .87) and acceptable for Cons (α = .75). The 
final items and their loadings in the confirmatory subsample are presented in Figure 1. 
Self-efficacy 
 The following measurement models were compared for the Self-efficacy scale: 
(1) a null model that supported six independent variables and no latent factors and (2) 
a single factor model. The one-factor model had the best fit. Factor loadings ranged 
from .67 to .86 and there was excellent model fit, χ²(9)=30.39, p<.01, CFI=.98, 
RMSEA =.09. Internal consistency was excellent (α = .90). Final items and their 
loadings are presented in Figure 2. 
External Validation 
 External validity was evaluated in two ways. First, the relationship between 
TTM constructs and Stages of Change was evaluated and compared to patterns seen in 
other areas of behavior change (Figure 3 and Figure 4). Raw TTM construct scores 
(see Table 2) were translated to T scores and weighted by group size to eliminate bias 
created from uneven Stage groups. Second, relationships between TTM constructs and 
anxiety severity were evaluated for predicted relationships.  
Decisional Balance by Stages of Change 
 Multivariate analysis of variance (MANOVA) indicated the individuals at 
different Stages of Change (vis-a-vis regularly approaching feared experiences) 
differed significantly on Decisional Balance constructs (F (8, 584) = 4.27, p<0.01, 2= 
.028). Follow-up ANOVAs indicated that there were significant between-stage 
differences on the Pros (F (4, 589) = 7.94, p<.01, 2=0.05). Post-hoc analyses 
indicated that the Pros were significantly higher for individuals in the Action and 
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Maintenance stages than for those in the Precontemplation stage. Pros showed a 
maximum average difference of .62 standard deviation units between 
Precontemplation and Maintenance. No significant between-stage differences were 
observed on the Cons (F (4, 589) = 0.75, p=0.56, 2=0.005). Cons showed a maximum 
average difference of .30 standard deviation units. Weighted T Scores of Pros and 
Cons at each Stage of Change are presented in Figure 3. 
Self-efficacy by Stages of Change 
 Analysis of variance (ANOVA) indicated that Self-efficacy was significantly 
different across the Stages of Change, F(4, 589) = 10.13, p<.01, 2=0.06. Follow-up 
comparisons showed that Self-efficacy of individuals in the Precontemplation and 
Preparation stages was substantially lower than that of those in the Action and 
Maintenance stages. Self-efficacy was .69 of a standard deviation unit higher among 
individuals in Action compared to individuals in Precontemplation. Weighted T 
Scores of Self-efficacy at each Stage of Change are presented in Figure 4. 
Relationships Between TTM Constructs and Severity of Anxiety 
 A series of linear regressions were performed to evaluate the relationship 
between anxiety severity (OASIS) and TTM constructs (Pros, Cons, and Self 
Efficacy). Results indicated that higher perceptions of the importance of the Pros of 
managing anxiety was associated with more severe levels of anxiety (β = 0.17, p<.01). 
Higher perceptions of the importance of the Cons of managing anxiety were also 
associated with more severe levels of anxiety (β = 0.25, p<.01). Finally, higher Self-
efficacy was associated with lower levels of anxiety severity (β = -0.29, p<.01). 
DISCUSSION 
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This is one of the first studies to apply the TTM, beyond generic Stages of 
Change measures, to anxiety. Measurement development results demonstrated good 
construct validity for two TTM scales, one measuring Decisional Balance and the 
other measuring Self-efficacy, in a large national sample of adults with clinically 
significant levels of anxiety. Both scales also demonstrated good external validity in 
terms of their relationship with Stages of Change. Data on average scores in each 
Stage of Change on these scales can be used in future research as the foundation for a 
CTI. 
Decisional Balance 
Through a sequential process of measurement development, this research 
supported a two factor correlated model for the Decisional Balance scale with one 
factor representing the Pros and the other the Cons of reducing anxiety-based 
avoidance. A two-factor model for Decisional Balance has been observed across many 
health risk behaviors. The findings are also consistent with the broader literature on 
Decisional Balance insofar as the Cons outweighed the Pros in Precontemplation, Pros 
are nearly equal to Cons in Contemplation, and there was a crossover in perceived 
importance of Pros versus Cons in the Contemplation Stage of Change.49 Also, Pros 
rose significantly as people progressed to the Action and Maintenance Stages of 
Change.48,49 
Findings also showed some differences between Decisional Balance applied to 
anxiety-based avoidance and Decisional Balance in other problem areas. First, the 
change in Pros was lower in magnitude than has been observed in other behavior 
areas. The change in Pros was 0.62 standard deviation units and changes closer to 1.0 
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standard deviation units are typically observed.48,49 One interpretation of this is that 
Pros of changing anxiety-based avoidance may be fairly important even when 
individuals are not taking action. Second, cross-stage differences in the perceived 
importance of Cons were not significant, so even among individuals who were 
regularly approaching feared stimuli, the downsides of challenging their anxiety in this 
way felt important. This may be one reason why drop out rates from evidence-based 
treatments are high. If these findings are replicated in future research, CTIs may 
benefit from a greater focus on feedback to increase the salience of Pros rather than to 
reduce the perceived importance of Cons.  
The positive relationship between the severity of anxiety and both perceived 
Pros and Cons of approaching anxiety-producing stimuli provided further external 
validation for the Decisional Balance measure. It was predicted that individuals with 
high anxiety would be keenly aware of the upsides of reducing avoidance. It was also 
predicted that the higher one’s anxiety would be more aware of the Cons of 
approaching feared-stimuli. Findings confirmed both predictions. 
Self-efficacy 
As hypothesized, results supported a single factor scale assessing Self-efficacy. 
Confirmatory fit indices for the Self-efficacy scale showed good fit. As observed in 
other areas of behavior change, Self-efficacy was greater among individuals in the 
Action and Maintenance stages than in the pre-Action stages. Contemplation was an 
exception insofar as the difference between Self-efficacy in Contemplation and that in 
Action and Maintenance was not significant, however, this finding may be a result of 
the small sample size of participants in Contemplation.51,67 Therefore, it appears that 
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individuals in more advanced Stages of Change for approaching anxiety-producing 
stimuli report greater situational Self-efficacy. Finally, the significant relationship 
between higher Self-efficacy and lower severity of anxiety provides additional 
external validation for this measure. These results support the validity of this scale and 
indicate that Self-efficacy may be a fruitful construct for feedback in a CTI aimed at 
reducing anxiety-based avoidance.  
Limitations & Future Directions 
 This study has several limitations. First, approximately 60% of this sample was 
in Action or Maintenance and less than 4% was in Contemplation. Sample sizes were 
adequate for principle component analyses and structural equation modeling 
conducted and scores were weighted by sample size for external validation analyses. 
Nevertheless the small Contemplation sample size likely limited the power for 
comparisons with other stage groups. Additionally, the dominance of individuals in 
Action and Maintenance may have affected observed loadings. Future research re-
evaluating findings in a pre-Action sample is warranted. Second, findings are based on 
cross-sectional comparisons of individuals in each Stages of Change. Cross-sectional 
findings provide some insight into factors that drive change, but do not necessarily 
have longitudinal implications. Finally, present findings are based on a sample of 
convenience. Although efforts were made to recruit a racially and ethnically diverse 
group of participants the vast majority of participates were white and non-Hispanic. 
Representation of minorities is not too disparate from national or racial minority 
representation according to US Census data, but additional research looking at the 
validity of developed measures in non-white groups would shed light on the 
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generalizability of these measures. The sample was also not representative of 
treatment-seeking rates in the general population insofar as the majority of participants 
were in some sort of treatment for anxiety. Further evaluation of both validity and 
stage-construct relationships is needed in a sample of non-treatment seeking, anxious 
adults.   
This study suggests several useful directions for future investigation. First, 
these findings should be evaluated longitudinally and in minority populations. Second, 
developing measures for the Processes of Change will be a key step toward building 
theoretically sound, population-based, computer-tailored intervention for managing 
anxiety. Finally, this study calls for further investigation into potential differences in 
the change process for behaviors aimed at improving emotional health, especially in 
the pattern observed in Decisional Balance variables.  
Conclusions  
Anxiety disorders are a major public health concern both in terms of personal and 
societal cost. Exposure-based therapy for anxiety disorders, which involves reducing 
avoidance or approaching successively more anxiety-provoking stimuli, is effective, 
but only a minority of the population of individuals with anxiety disorders engage in 
such treatment. This study developed and applied constructs from the TTM to 
approaching anxiety-provoking stimuli as an individual would do in evidence-based 
psychotherapy for anxiety. 
Results show considerable consistency with observations from other behaviors in 
that a two-factor Decisional Balance scale and one-factor Self-efficacy scale provided 
the best fit to the data. Also consistent with theory-based predictions, participants in 
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later Stages of Change scored higher on Pros and higher on Self-efficacy than 
individuals in earlier Stages of Change. Scales also showed a sound relationship with 
anxiety severity. The scales developed in this study may be useful for a variety of 
purposes, including assessing readiness to engage in exposures in the context of 
intervention and research. Computerized interventions that provide feedback tailored 
to Stage of Change and other TTM constructs like Decisional Balance and Self-
efficacy, have been found to be an effective population-based intervention in a variety 
of other areas of behavior change.42,68-70 Such an approach may be necessary to 
improve the impact of evidence-based treatments for anxiety such that we are 
intervening on the full population of individuals with anxiety disorders. 
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SO WHAT? 
What is already known on this topic? 
Exposure-based treatment for anxiety is effective, but reach of these treatments is 
limited owing to limited access and other individual variables like beliefs about 
treatment and motivation. Research efforts to date have focused on increasing access 
and less on understanding motivational influences and how to intervene on them. 
What does this article add? 
This article described development and validation of Self-efficacy and Decisional 
Balance scales, two constructs that have been found to mediate behavior change for 
many behaviors. The relationship between these scales and readiness to change 
supports their importance in reducing avoidance in anxious individuals.  
What are the implications for health promotion, practice, or research? 
Utilization of the Transtheoretical model allows the field to move beyond treatment 
studies based on an action-ready paradigm and traditional modes of in-person 
treatment that are not likely to dramatically increase utilization. These measures can 
be used as the basis for a population-based CTI.  
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Table 1.  
 
Robust Method Fit Indices for Evaluated Decisional Balance and Self-Efficacy Confirmatory Models 
 
 χ²(df) CFI RMSEA (CI) 
Decisional Balance    
Model 1: null model 788.80 (45)* -- -- 
Model 2: uncorrelated two factor model 80.82 (35)* .938 .066 (.047, .084) 
Model 3: correlated two factor model 68.23 (34) * .954 .058 (.037, .077) 
Self-efficacy    
Model 1: null model 907.42(15) * -- -- 
Model 2: one factor model 30.39(9) * .976 .088 (.055, .124) 
 
Note. N = 305; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; RMSEA = root mean  
square error or approximation; CI = confidence interval; *p<0.01. 
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Table 2.  
Summary of Raw Scores on Pros, Cons, and Self-Efficacy by Stage 
  Pros Cons Self-Efficacy 
Stage N Mean S.D. Mean S.D. Mean S.D. 
Precontemplation 84 18.21 4.64 15.76 3.99 12.85 5.68 
Contemplation 23 19.30 4.03 14.96 4.45 14.13 3.31 
Preparation 123 20.58 4.28 15.72 4.10 13.49 4.24 
Action 101 20.71 3.63 15.91 4.54 16.28 5.21 
Maintenance 263 20.78 3.44 16.25 4.40 15.82 5.21 
 
Note. Mean = average sum score, higher scores indicate more importance for Pros and Cons and more confidence for Self-Efficacy; 
S.D. = standard deviation. 
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Figure 1.  
Decisional Balance Structural Model (N=305) 
 
 
Pros 
(α=.87) 
Cons 
(α=.75) 
.28 
If I managed my anxiety, I 
would be able to do things that 
are important to me. 
I would be more fun to spend 
time with if I managed my 
anxiety. 
Managing my anxiety would 
improve my health. 
Managing my anxiety could 
improve my relationship with 
others. 
Managing my anxiety would 
make me feel like a stronger 
person. 
Purposefully doing some of the 
things that make me anxious 
would be upsetting. 
Trying to do some of the things 
that make me anxious could be 
embarrassing. 
Managing my anxiety would 
take resources (time and 
money) I don't have. 
If managing my anxiety made 
me less anxious, others would 
expect more from me. 
I am concerned that if I tried to 
manage my anxiety it may get 
worse. 
.77
.66
.79
.83
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.66
.59
.49
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.70
CFI = .95 
RMSEA = .06 (CI: .04, .08) 
Χ2 = 68.23* (df = 34) 
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Figure 2.  
 
Self-Efficacy Structural Model (N=305) 
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Figure 3.  
 
Stage of Change by Decisional Balance 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance.  
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Figure 4.  
Stage of Change by Self-efficacy 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance.  
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Abstract 
Anxiety is the most prevalent form of mental illness. Effective treatments exist, 
but are underutilized. Treatments vary but uniformly involve reducing avoidance of 
anxiety-producing stimuli. The Transtheoretical Model (TTM) provides a theoretical 
framework for designing interventions that improve reach. This study describes the 
development and validation of a measure of Processes of Change (POC), a core TTM 
construct representing the emotional, cognitive and behavioral elements of the change 
process. Cross-sectional measurement development with online survey dissemination 
was used in 594 adults reporting clinically significant anxiety. Confirmatory analyses 
replicated the theoretically-expected structure of the POC scales. Most effect sizes 
were in the medium range, indicating that POC represent important behavior change 
strategies for reducing anxiety-based avoidance. Relative effect sizes for the POCs 
indicate which POCs individuals with low readiness may need to focus on. The 
resulting measure can be used to design interventions that both increase readiness and 
guide those ready to take action. 
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Anxiety is the most prevalent form of mental illness in the United States. Lifetime 
prevalence estimates indicate that a quarter of the general population in the United 
States will experience an anxiety disorder at some point in his or her life (Kessler et 
al., 2005). Compared to the general population, individuals with anxiety disorders 
experience lower quality of life as well as educational and occupational impairment 
(Barrera & Norton, 2009; Breslau, Lane, Sampson, & Kessler, 2008; Comer et al., 
2011; R C Kessler, 2003; Lee et al., 2009; Olatunji, Cisler, & Tolin, 2007; Patel, 
Knapp, Henderson, & Baldwin, 2002). They are also more likely to develop comorbid 
medical problems and more likely to commit suicide (Bolton et al., 2008; Comer et al., 
2011; Harter, Conway, & Merikangas, 2003; Katon, Lin, & Kroenke, 2007; Sareen et 
al., 2005). Alongside these substantial personal costs, anxiety disorders have a large 
public health cost. They account for approximately a third of total expenditures on 
mental illness and have an annual estimated cost in the US ranging from $42 to $46 
billion dollars (DuPont et al., 1998; Greenberg et al., 1999; Stein et al., 2005) 
Many randomized control trials indicate that cognitive-behavioral treatments 
(CBTs) for anxiety are effective. Effect sizes for these treatments are consistently 
large (d = 1.14 to 1.98; Norton & Price, 2007), and a majority of patients show a 
positive response to these treatments (Barlow, Allen, & Choate, 2004). Exposure—the 
process of confronting stimuli that the patient would usually avoid because of anxiety, 
starting with less anxiety-provoking stimuli and working up to more difficult 
stimuli—is a key component of evidence-based behavioral treatments for anxiety 
(Norton & Philipp, 2008). Dismantling studies aimed at determining the active 
components of evidence-based treatments for anxiety indicate that exposure-only 
 64 
 
treatments often perform as well as evidence-based therapies with exposure plus 
cognitive components (Deacon & Abramowitz, 2004; Eddy, Dutra, Bradley, & 
Westen, 2004; Feske & Chambless, 1995; Foa et al., 2005; Gould, Otto, Pollack, & 
Yap, 1997; Hope, Heimberg, & Bruch, 1995; Lovell, Marks, Noshirvani, Thrasher, & 
Livanou, 2001; Ougrin, 2011; Paunovic & Ost, 2001; Rosa-Alcazar, Sanchez-Meca, 
Gomez-Conesa, & Marin-Martinez, 208; Scholing & Emmelkamp, 1993). 
Unfortunately, most individuals with anxiety disorders do not receive exposure-
based therapy. Only 4-11% of individuals with anxiety disorders seek mental health 
treatment at all (Mojtabai, Olfson, & Mechanic, 2002; Young, Klap, Sherbourne, & 
Wells, 2001). Research suggests that the main reasons for not getting treatment are: 
poor access (encountering logistical barriers such as cost and availability) and intra-
individual variables that affect readiness (not being receptive to treatment or not 
believing one’s symptoms warrant treatment; Weisberg, Dyck, Culpepper, & Keller, 
2007). Intra-individual barriers are particularly relevant in exposure therapy because 
approaching feared stimuli is a difficult and counterintuitive way to address anxiety 
(Gunter & Whittal, 2010). To date, efforts to improve the reach of evidence-based 
treatments for anxiety have focused on increasing access, for example by training 
more providers, providing group treatment, making treatments available in non-
specialty settings (Gunter & Whittal, 2010; McHugh, Murray, & Barlow, 2009), rather 
than reducing intra-individual barriers.  
The Transtheoretical Model Of Behavior Change (TTM) 
The TTM provides an integrative framework for developing interventions that are 
relevant to the full population of individuals exhibiting a particular problem behavior 
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(e.g., anxiety-based avoidance) rather than the smaller segment of the population who 
are ready to take action (Prochaska & DiClemente, 1983).  Numerous randomized 
controlled trials support the effectiveness of interventions that provide both tailored 
feedback based on individuals’ use of particular readiness-matched behavioral and 
cognitive elements of the change process. Such TTM-tailored interventions have been 
used to promote behavior change in a variety of areas ranging from engaging in 
physical activity to managing depressive symptoms to reducing domestic violence 
(Levesque, Ciavatta, Castle, Prochaska, & Prochaska, 2012; Levesque et al., 2011; 
Marcus et al., 1998).  
The TTM posits that individuals differ in their readiness to make changes. 
Readiness is classified within five dynamic Stages of Change: Precontemplation (not 
intending to take action in the foreseeable future), Contemplation (intending to take 
action in the near future, but not immediately), Preparation (intending to take action in 
the immediate future), Action (initiating the new behavior pattern) and Maintenance 
(>6 months of successful behavior change). These stages are conceptualized as 
dynamic in that individuals frequently migrate between stages both in the direction of 
progress toward change and in the direction of regression away from change. 
 Alongside this temporal classification of change are two other constructs—
Decisional Balance and Self-efficacy—which represent the “why” part of the change 
process. Decisional Balance refers to an individual’s perception of the relative weights 
of advantages and disadvantages of change (Velicer, DiClemente, Prochaska, & 
Brandenburg, 1985). Self-efficacy refers to an individual’s level of confidence in his 
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or her ability to change a target behavior in a variety of challenging situations 
(Velicer, Diclemente, Rossi, & Prochaska, 1990).  
The TTM also specifies ten Processes of Change (POC) that describe the 
“how” part of behavior change. The POC are a set of cognitive, emotional and 
behavioral experiences or strategies in which individuals engage at different points of 
the change process (DiClemente & Prochaska, 1982; Prochaska, Velicer, DiClemente, 
& Fava, 1988). These POC are conceptualized as ten independent but interrelated 
variables that influence Decisional Balance and Self-efficacy and can be used to 
promote successful change. The 10 POC include two groups: experiential POC which 
are the cognitive and emotional aspects of the change process and behavioral POC 
which are the overt activities that facilitate change (DiClemente & Prochaska, 1982; 
Prochaska, DiClemente, & Norocross, 1992). Experiential POCs include 
Consciousness Raising (increasing information about how change could impact one’s 
life), Dramatic Relief (emotional reactions to the problem behavior), Environmental 
Reevaluation (assessing how the problem behavior affects one’s environment), Self-
reevaluation (assessing conflicts between one’s sense of self and the problem 
behavior), and Social Liberation (increasingly recognizing alternatives to the problem 
behavior). Behavioral POCs include Self Liberation (affirming one’s commitment to 
change), Reinforcement Management (rewarding oneself or receiving rewards for 
taking steps toward change), Helping Relationships (increasing social support for 
behavior change), Counterconditioning (substituting problem behaviors with healthier 
behaviors), and Stimulus Control (increasing cues for positive behaviors and removing 
cues for the behavior one is trying to change; Prochaska et al., 1992).   
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The relationship between Stage of Change and POC is not uniform across 
problem behaviors. For example, in smoking and substance abuse, experiential POC 
are used more frequently in pre-Action stages of change and behavioral POC are used 
more frequently in Action and Maintenance (Prochaska, Velicer, Diclementa, & Fava, 
1988; Rosen, 2000). In behaviors such as insufficient exercise and unhealthy dietary 
habits, use of both behavioral POC and experiential POC seem to either remain steady 
or increase from earlier to later stages of change (Gorely & Gordon, 1995; Beth H 
Marcus, Rossi, Selby, Niaura, & Abrams, 1992; Oliveira, Anderson, Auld, & Kendall, 
2005). One theory on these differences is that the type of behavior (e.g., acquisition 
behaviors where a new activity is being initiated versus cessation behaviors where a 
problematic behavior is being stopped) may determine the pattern of POC use across 
stage (Rosen, 2000). Creating interventions tailored to individuals’ readiness to 
change a given behavior requires an understanding of which POCs are most important 
at each level of readiness.   
Current Study 
 Applications of the TTM to anxiety have been limited. Several studies have 
evaluated the relationship between various treatment factors (initiation, dropout and 
treatment outcomes) and Stage of Change (Al-Asadi, Klein, & Meyer, 2014; Pinto, 
Pinto, Neziroglu, & Yaryura-Tobias, 2007; Reid, Nair, Mistry, & Beitman, 1996; 
Woolf et al., 2006). Also, while not directly related to the TTM, several recent studies 
have shown improved treatment engagement and clinical outcomes when readiness-
enhancing interventions like Motivational Interviewing and Motivational 
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Enhancement Therapy (MET) are used as pretreatments for CBT (Buckner & 
Schmidt, 2009; Westra, Arkowitz, & Dozois, 2009; Westra & Dozois, 2006).  
 In order to design anxiety interventions using a TTM framework, core 
constructs of the TTM as they relate to anxiety must be defined and measureable. The 
current study builds upon existing literature (which suggests that readiness affects 
treatment outcomes) by defining a core TTM construct, Processes of Change, as it 
relates to anxiety. Specifically, in this study a POC measure for anxiety-based 
avoidance—the central behavior change target for evidence-based treatments for 
anxiety—was developed and evaluated for validity. Secondary aims were to evaluate 
the relationship between the TTM POCs and readiness to address anxiety-based 
avoidance and to develop data-driven guidelines for POC use across stages. This could 
guide tailoring algorithms for a computer-delivered, readiness enhancing, intervention 
for anxiety. 
METHODS 
Measure Development Process 
 A sequential process of measurement development was used in this study 
(Jackson, 1970; Redding, Maddock, & Rossi, 2006). This approach involves item 
development and refinement via literature review, expert interviews and qualitative 
interviews with individuals in the population of interest. Data are then collected on the 
items developed, and a series of structural equation modeling analyses are used to 
refine the POC scales. Finally, external validation analyses are conducted. These 
involve testing for predicted relationships between POC use and other TTM constructs 
such as stage, Decisional Balance and Self-efficacy.  
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 Item Development. For this study, item development involved interviews with 
two anxiety experts. Items generated were then blindly rated for construct consistency 
by six TTM experts. Items that were not classified as measuring the intended Process 
of Change by a majority of TTM expert raters (i.e., at least 4 out of 6) were excluded 
from final survey used for data collection.  
Items developed via expert interviews were further evaluated via qualitative 
interviews with individuals from the population of interest. Qualitative interviews 
were intended to check items for clarity, acceptability, and face validity. Items that 
consistently raised questions or other problems among the interviewees were 
discussed by the project team and eliminated or modified. Interviews were conducted 
until data saturation was reached (n=10).  
Data Analyses. Data for structural equation modeling analyses were collected 
by Survey Sampling International (SSI), an online survey sampling company, using 
FluidSurveysTM online survey software. Data were extracted from FluidSurveysTM into 
both EQS for structural equation modeling analyses and SPSS for external validation 
analyses.  
Iterative Confirmatory Factor Analyses (CFAs) were the primary tool used for 
measurement development. The aims of these analyses were to (1) generate estimates 
factor loadings and (2) evaluate internal consistency for each factor using Cronbach’s 
alpha. Item selection was an iterative process in which items with poor loadings 
(<.40), complex loadings (>.40 on more than one factor), as well as items with lower 
loadings and content redundancy were removed. Analyses were then repeated. Final 
item selection was also based on item clarity and conceptual breath.  
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Once the final set of items was selected, alternative measurement models were 
compared using CFA to determine which factor structure provided the best fit to the 
data. Robust estimation methods (as opposed to maximum likelihood methods) were 
used given the ordinal nature of measurement data. In order to determine the model 
with the best fit, three fit indices were used: the Satorra-Bentler scaled chi-square 
statistic (Χ2), the comparative fit index (CFI), and the root mean square error of 
approximation (RMSEA). Traditionally, CFI values of 0.90 and above are considered 
to indicate good fit (Hu & Bentler, 1999). RMSEA values between .05 and .08 suggest 
reasonable error of approximation, and values >1 indicate poor fit (Browne & Cudeck, 
1993).  
External validation involved evaluating the degree to which data confirmed the 
TTM-based prediction that (i) individuals in different Stages of Change will differ 
significantly on their scores for the POC subscales and (ii) POCs will be correlated 
with other TTM constructs. Multivariate Analysis of Variance (MANOVA) was 
conducted to evaluate differences in POC across stage. To facilitate comparison 
between the magnitude of differences across stage in scores among the different 
subscales and the results of the current and previous studies, raw scores were 
converted to T-scores (M = 50, SD = 10). Correlations between POC subscales and 
other TTM variables (Pros, Cons and Self-Efficacy) were also examined.  
Participants 
Recruitment. To be eligible for either phase of the study (qualitative 
interviews or online survey administration), individuals had to be over the age of 18 
and score an 8 or above on the Overall Anxiety Severity and Impairment Scale 
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(OASIS), which has been found to indicate clinically significant anxiety (Campbell-
Sills et al., 2009). Participants for qualitative interviews were recruited through flyers 
placed at universities, community centers, and mental health treatment centers. Flyers 
directed interested participants to call the primary investigator, at which point they 
were consented to engage in a screening questionnaire for eligibility (age and OASIS 
score). Twenty individuals called to express interest in participating. Thirteen of these 
individuals were eligible to participate and ten opted to come in for qualitative 
interviews. Qualitative interview participants were reimbursed $20 for their 
participation. The sample for the online survey administration was recruited through 
Survey Sampling International, an online survey sampling company. 
Sample Characteristics. Ten individuals participated in qualitative interviews. 
The average age of cognitive interview participants was 36.6 and the average OASIS 
score was 11.3. Three of the qualitative interview participants were recruited from a 
local mental health treatment center, four were recruited from a community support 
center, and three were recruited from the University of Rhode Island community. 
Seven of the qualitative interview participants were male and three were non-white. 
SSI recruited 594 eligible adults to participate in the online survey portion of 
this study. The sample was primarily female (69.4%, n=412), and ages ranged from 18 
to 80 (M = 38.6, SD = 13.8). The majority of the sample was White (n=454, 76.4%), 
12.8% were Black (n=76), 3.7% were Asian (n=22), and 7.1% classified themselves as 
not fitting any of these racial categories (n=42). Of the 594 participants, 14.1% were 
in Precontemplation (n=84), 3.9% were in Contemplation (n=23), 20.7% were in 
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Preparation (n=123), 17.0% were in Action (n=101), and 44.3% were in Maintenance 
(n=263).  
Measures  
Measures Used 
Overall Anxiety Severity and Impairment Scale (OASIS; Norman, Hami-
Cissell, Means-Christensen, & Stein, 2006). The OASIS was used to determine 
eligibility for participation. The OASIS is a 5-item self-report measure that evaluates 
severity and impairment associated with any anxiety disorder. Participants rate the 
degree to which each item describes them over the past week on a 5-point scale 
ranging from 0 (None) to 4 (Extreme/All the Time). A cutoff score of 8 or greater has 
been found to accurately classify 87% of individuals as having an anxiety diagnosis 
(Campbell-Sills et al., 2009). This scale was selected based on its strong psychometric 
properties, adequate coverage of symptoms relevant for all anxiety diagnoses, and ease 
of use (i.e., short length, free access, and easy scoring). Good internal (α=0.80) and 
one-month test-retest reliability (κ = 0.82) have been reported. Research shows strong 
convergent validity with other measures of anxiety (Norman, Hami-Cissell, Means-
Christensen, & Stein, 2006). 
Stage of Change. Participants were asked to answer a series of questions about 
whether they regularly challenge their tendency to avoid anxiety-producing stimuli. 
Questions placed participants in one of five mutually exclusive Stage of Change 
categories. The behavioral target or criterion for assigning an individual to the Action 
stage, was defined as “at least once a week, you push yourself to approach some of the 
things that you often avoid (or choose not to do) because of anxiety.” This criterion 
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was based on evidence that exposure to feared stimuli reduces symptoms of anxiety 
and impairment from anxiety. For pre-action stages, participants were assigned to 
Precontemplation if they indicated that they were not currently approaching feared 
stimuli regularly and did not intend to do so in the next six months; Contemplation if 
they were not currently approaching feared stimuli regularly, but intended to begin 
doing so in the next six months; and Preparation if they were not currently 
approaching feared stimuli regularly, but intended to begin doing so in the next 30 
days. Participants were assigned to Action if they reported currently meeting the 
Action criterion and were assigned to Maintenance if they reported having been 
engaged in this behavior for at least six months. 
Decisional Balance. The Decisional Balance scale included 10 items designed 
to assess the relative importance of Pros (5 items) and Cons (5 items) of reducing 
anxiety-based avoidance. Examples of items were “managing my anxiety could 
improve my relationship with others” (Pro) and “trying to do some of the things that 
make me anxious could be embarrassing (Con). Ratings were based on 5-point Likert 
scale ranging from 1 = ‘Not Important at All’ to 5= ‘Extremely Important.’ The score 
for this scale was the sum of a participant’s responses. 
Self-efficacy. Six items were used to develop evaluate Self-efficacy or 
participants’ confidence in their ability to approach feared stimuli regularly in a 
variety of challenging situations (e.g., “when my schedule is very busy”). Participants 
indicated their confidence levels on a 5-point Likert scale, ranging from 1 = “Not at 
All Confident” to 5 = “Extremely Confident. The total score for this scale consisted of 
the sum of the participant’s responses. 
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Measures Developed 
 Processes of Change. An initial pool of 93 items reflected the 10 POC. 
Participants were asked to rate the frequency in which they engaged in an array of 
cognitive, behavioral and emotional reactions to their anxiety and the avoidance it 
encourages. Participants indicated the frequency with which they engaged in each 
activity on a 5-point Likert scale, ranging from 1 = “Never” to 5 = “Frequently” (final 
items listed in Table 1). 
RESULTS  
Processes of change  
The 10-factor fully correlated model fit the data best, χ²(360)=905.82, p<.01, CFI=.94,  
RMSEA =.051 (see Table 1). Factor loadings ranged from .53 to .85 and coefficient 
alphas ranged from .69 to .88. Table 2 shows the fit indices for the models that were 
evaluated. The null model supports 30 independent variables and no latent factors. The 
ten-factor model specifies 10 correlated latent factors each with three items loading on 
them. Finally, the two higher order factor model was a hierarchical model, which 
specified two, correlated factors, representing experiential and behavioral POC 
respectively, each with five latent POC variables loading on them and respective items 
loading on the latent POC variables (see Figure 1 in the appendix).  
External validation 
 POC and Stage of Change. Multivariate Analysis of Variance (MANOVA) 
found a significant main effect for Stage of Change (Wilk’s Λ=.72, F(40, 2201.1) = 
4.89, multivariate η2= .08). This indicates that use of the POC subscales differed 
significantly by Stage of Change. Follow-up ANOVA values are as follows: 
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Consciousness Raising F(4, 589) = 13.03, p<.01, η2= .08; Dramatic Relief F(4, 589) = 
5.89, p<.01, η2= .04; Environmental Reevaluation F(4, 589) = 8.26, p<.01, η2= .05; 
Self-Reevaluation F(4, 589) = 18.81, p<.01, η2= .11; Social Liberation F(4, 589)  
19.23, p<.01, η2= .12; Self-liberation F(4, 589) = 26.83, p<.01, η2= .15; Reinforcement 
management F(4, 589) = 21.21, p<.01, η2= .13; Helping relationships F(4, 589) = 
8.80, p<.01, η2= .06; Counterconditioning F(4, 589) = 30.09, p<.01, η2= .17; and 
Stimulus Control F(4, 589) = 29.98, p<.01, η2= .17. Figures 1 and 2 show the 
experiential and behavioral POC comparisons by stage respectively.  
Table 3 shows the results of post-hoc tests evaluating which stages showed 
significant differences for each POC subscale. Findings showed that individuals in 
Precontemplation used experiential POC less than individuals in all other stages with 
the exception of Consciousness Raising and Social Liberation. Results showed that 
individuals in Precontemplation, Contemplation and Preparation used behavioral POC 
less (with the exception of Helping Relationships) than those in Action and 
Maintenance. All three exceptions to the patterns specified above were differences 
between individuals in Contemplation and other stages, which may have been a 
function of the small sample size of participants in Contemplation. 
POC, Decisional Balance and Self-efficacy. Experiential POC and behavioral 
POC were summed and two higher order constructs were created in order to evaluate 
the relationships between POC, Decisional Balance and Self-efficacy. Correlations 
among the POC factors (experiential and behavioral), Decisional Balance (Pros and 
Cons), and Self-efficacy were then evaluated. Experiential POC and behavioral POC 
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were significantly positively correlated with one another as well as with Pros, Cons 
and Self-efficacy (Table 4).  
DISCUSSION 
The primary goal of this study was to develop a psychometrically and 
conceptually sound measure of TTM Processes of Change relevant for reducing 
anxiety-based avoidance. To our knowledge, this is the first study to apply the TTM 
Processes of Change to anxiety. Items had strong content and face validity per expert 
interviews and qualitative interviews with participants. Confirmatory factor analyses 
performed on the final set of items supported a correlated, ten-factor model structure, 
which has been observed in POC measures for a number of other behaviors (Amoyal 
et al., 2013; Fernandez et al., 2013; Marcus et al., 1992). Items demonstrated strong 
loadings on factors (ranging from .53 to .85), and POC subscales for the final 
measures showed good internal consistency (alphas ranged from good .88 for Helping 
Relationships to acceptable .69 for Environmental Reevaluation; Costello & Osborne, 
2005).  
This study adds to a base of literature that has compared fit indices between 
alternative factor structures for the POC. In one hypothesized factor structure, the five 
experiential and behavioral POCs each load on one of two correlated higher order 
factors, one representing the experiential POC and the other representing the 
behavioral POC (see Figure C1 in appendix). The alternative factor structure tested 
was a 10-factor, fully correlated model. In this study, the 10-factor correlated model 
was a better fit to the data. Taken together with previous findings that support the 10-
factor, correlated model over the two higher order factor model (Amoyal et al., 2013; 
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Fernandez et al., 2013; Beth H Marcus et al., 1992), these results raise the question of 
whether the division of POCs into two groups (experiential and behavioral) is more 
conceptually- than data-driven. Further evaluation of the factor structure that best fits 
data in different areas of behavior change is needed to determine the empirical 
distinction between experiential and behavioral POCs. 
Similar to studies of POC measures for other behaviors, our findings indicated 
reliable differences in POC use across Stage of Change. Overall experiential POC use 
showed the biggest differences between Precontemplation and Contemplation, 
whereas behavioral POC showed the biggest differences between Preparation and 
Action. Some experiential POC, namely Dramatic Relief and Environmental 
Reevaluation, showed flattening after Contemplation, which indicates that intervening 
to increase use of these processes may be most important in early stages. Additionally, 
participants in all pre-Action stages use most behavioral POC significantly less than 
participants in Action/Maintenance. In contrast, significant differences in experiential 
POC use were mainly between Precontemplation and all other stages. This finding 
supports a distinction between experiential and behavioral POCs insofar as they 
appear to be used most frequently in different stages of the change process. Another 
pattern observed that is consistent with previous literature and supports the external 
validity of this measure was that Precontemplators reported using POCs significantly 
less frequently than individuals in Action and Maintenance for all POCs (Prochaska & 
DiClemente, 1983). 
Cross-stage effect sizes were mostly in the small to medium range. As has 
been observed in some other areas of behavior change, effect sizes were consistently 
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larger for behavioral POCs than experiential POCs (Marcus et al., 1992). Among 
experiential POCs, Self-reevaluation and Social Liberation showed the largest effect 
sizes. Among the behavioral POC, Counterconditioning and Stimulus Control showed 
the largest effect sizes. Differences in effect size provide insight into which POC may 
be most useful to intervene on at different levels of readiness.  
Relationships between POCs and other TTM constructs were evaluated as a 
means of external validation. The expectation is that as Decisional Balance and Self-
efficacy shift in favor of change, POC will be used more frequently. As hypothesized, 
experiential and behavioral POCs were positively correlated with the perceived 
importance of Pros of reducing avoidance as well as with Self-efficacy (that one could 
maintain a commitment to approaching feared stimuli across a range of challenging 
situations). This study found a significant positive correlation between POC and 
perceived importance of Cons of change, a result that has also been found for some 
other behaviors (e.g., Amoyal et al., 2013). One interpretation of this finding is that 
Cons do not deter participation in change-related cognitive and behavioral activities 
and may be keenly experienced throughout the change process. 
 A few correlations between TTM variables were particularly high and, 
therefore, warrant additional discussion. Namely, Pros were most highly correlated 
with experiential POC, and Self-efficacy was most highly correlated with behavioral 
POC. These correlations may be owing to the relative importance of Pros and 
experiential POC in earlier stages and the relative importance of Self-efficacy and 
behavioral POC in the later stages. However, further exploration of potential causal 
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relationships between these variables (e.g., perception of the importance of Pros 
producing more frequent of engagement in experiential POC) would be worthwhile. 
Several limitations of this study should be acknowledged. First, this study 
utilized a cross-sectional design. Longitudinal studies will be necessary to evaluate the 
degree to which increasing POC use drives change and to enhance applicability of 
findings to intervention development. Second, the participant sample was 
predominantly white and non-Hispanic, which may limit the generalizability of 
findings to minority populations. Although factor structures and validity findings for 
TTM constructs have often generalized well to minority samples, the applicability of 
this scale to more diverse populations must be evaluated (Blaney et al., 2012). 
Additionally, the sample consisted of individuals who agreed to be part of a large 
survey-sampling company’s national database, which may have produced self-
selection bias. Finally, approximately half of our sample was in the Action or 
Maintenance Stage of Change. While stage by POC analyses were weighted for 
differing stage samples sizes, these sample characteristics may have affected the 
measurement development process. Also the particularly small sample size for 
individuals in Contemplation, is likely why comparisons between the use of POCs in 
the Contemplation and other stages were often not significant even when fairly large 
differences were observed. Future research evaluating findings with a more diverse 
sample, more equal stage distribution (or even a pre-Action only sample), and 
proactive recruitment that reaches out to a full population, rather than just those who 
sought out opportunities to participate in online surveys, is warranted. 
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The results of the present study have important theoretical and applied 
implications for treatment of anxiety disorders. Interventions for anxiety disorders 
need to be designed to treat both individuals who are ready to reduce their avoidance 
and individuals who are suffering from anxiety, but not ready to take the steps 
required to address it. This study developed a measure of ten strategies used to 
facilitate motivation and engagement in behavior change that can help guide clinicians 
and researchers in tailoring interventions to patients’ level of readiness. 
This measure can be used in the context of therapy and treatment research to 
evaluate the cognitive, behavioral, and emotional activities a patient or participant is 
engaging in and facilitate a more readiness-tailored intervention. Additionally, there is 
a strong precedent for using the TTM as a framework for developing computer-based 
interventions that can be used as an adjunct to in-person treatments or alone for those 
who do not have access to or are unwilling to seek in-person treatment. Such 
interventions involve administering a POC measure and providing feedback tailored to 
an individual’s score on the instrument as well as Stage of Change. These 
interventions are low-cost, accessible, and have been found to be effective in 
producing behavior change relevant for other mental health disorders (e.g., Levesque 
et al., 2011). Integration of stage-matched POC feedback into existing and new 
interventions has the potential to allow the field to take a more population-based 
approach that could help solve the knowledge-dissemination gap plaguing treatment of 
anxiety disorders. 
CONCLUSIONS 
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This study developed a reliable (internally consistent) and valid instrument for 
measuring TTM Processes of Change for reducing anxiety-based avoidance in anxious 
individuals. Findings also support the applicability of the TTM to anxiety-based 
avoidance insofar as the measurement structure and relationship between TTM 
constructs adhered to models observed in other behaviors. This POC instrument is 
appropriate for use in clinical settings and treatment research to design and implement 
readiness-matched interventions. It could also be used to develop a cost-effective, 
easy-to-access, TTM-based computer-tailored intervention, which has potential to 
have a large impact on the population of individuals with anxiety disorders who are 
not in treatment. 
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Table 1.  
 
Item Loadings from Confirmatory Factor Analysis and Coefficient Alpha’s for 
Experiential and Behavioral Processes of Change. 
 
Processes of Change  Factor Loadings
Experiential Processes 
Consciousness Raising (α=.80)   
     I search the internet for information on how to better manage my anxiety. 0.85 
     I pay attention to information from the tv, radio, and articles on how to manage 
my anxiety.  
0.70 
     I Google the effects of anxiety on my health and functioning.  0.75 
Dramatic Relief (α=.73)   
     I am disappointed when I notice that I missed or avoided something because of 
my anxiety. 
0.63 
     I feel sad when I see how anxiety affects my life. 0.76 
I feel frustrated when I compare myself to others who have less anxiety. 0.69 
Environmental Reevaluation (α=.69)   
     I consider that avoiding things because of my anxiety may make me a worse role 
model. 
0.53 
     I pay attention to how my anxiety affects my family. 0.70 
     I think that managing my anxiety may prevent me from being a burden on others. 0.74 
Self-reevaluation (α=.71)   
     I imagine a day when anxiety has less control over my life. 0.59 
     I think that addressing my anxiety would make me feel like a more confident 
person. 
0.69 
     I feel more like the person I want to be when I take steps to manage my anxiety. 0.74 
Social Liberation (α=.83)   
     I see that more and more people are getting help dealing with their anxiety. 0.76 
     I notice more opportunities to get support in managing my anxiety. 0.83 
     I notice the media are more open to covering people’s struggles with anxiety. 0.76 
Behavioral Processes 
Self-liberation  (α=.80)   
     I believe I can carry through with my goal to do some of the things that make me 
anxious. 
0.71 
     I renew my commitment to face my fears one step at a time. 0.77 
     I tell myself that I can approach things that make me anxious if I work at it. 0.78 
Reinforcement Management  (α=.83)   
     I give myself credit for the hard work I’m doing to manage my anxiety. 0.80 
     I do something nice to reward myself when I don’t give into the urge to avoid. 0.79 
     As I approach more things over time, if feels good to see that I’m becoming less 
anxious. 
0.78 
Helping Relationships  (α=.88)   
    I am supported by others in my efforts to stop avoiding things that make me 
anxious. 
0.83 
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    Friends or relative let me know they are there to help me manage my anxiety. 0.84 
    I see that I have someone who encourages me to manage my anxiety. 0.85 
Counter Conditioning  (α=.81)   
    When I start feeling anxious, I take time to practice mindfulness or to practice 
focusing on the    
               present moment.  
0.71 
    When I start having anxious thoughts, I practice challenging them. 0.78 
    I practice doing things that make me anxious, rather than avoiding them.  0.81 
Stimulus Control  (α=.81)   
     I organize my schedule in a way that requires me to face my fears. 0.79 
     I plan activities that encourage me to face the things that make me anxious. 0.81 
     I use my phone, computer or calendar to remind me to take steps to manage my 
anxiety. 
0.72 
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Table 2.  
Robust Estimation Method Fit Indices for Processes of Change Confirmatory Models 
     χ² (df)   CFI RMSEA (CI) 
 
Full null model   9268.90* (435) --  -- 
 
Ten factor model    905.82* (360)  0.94  .051 (.046, .055) 
 
Two higher order factor model 1334.40* (394) 0.89   .063 (.060, .067) 
 
 
Note. N= 594; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; 
RMSEA = root mean square error of approximation; CI = confidence interval; *p<.01. 
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Table 3.  
 
Stage Group Comparisons on Each of the Processes of Change 
 
Process     Comparisons of stage-of-change groups 
Consciousness raising   PC < PR/A/M 
Dramatic relief   PC < All 
Environmental reevaluation  PC < All 
Self-reevaluation   PC < All 
Social Liberation   PC < PR/A/M, PR<A/M 
Self Liberation   PC < PR/A/M, C < A/M, PR < A/M 
Reinforcement management  PC < PR/A/M, C < A/M, PR < A/M 
Helping relationship   PC < A/M, PR < A/M 
Counterconditioning   PC < PR/A/M, C < A/M, PR < A/M 
Stimulus control   PC < A/M, C < A/M, PR<A/M 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance; ALL = All other stages of change; p < .05, using Tukey tests. 
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 Table 4.  
 
Correlations between Processes of Change and other TTM constructs 
 
 Behavioral Processes Pros 
 
Cons 
Self- 
Efficacy 
Experiential 
Processes  
   .659* .546* .270* .312* 
Behavioral 
Processes  
  -- .210* .196* .601* 
Pros     -- .275* .074 
Cons      -- .045 
Self-Efficacy      -- 
 
Note. *p < 0.01 level (2-tailed). 
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Figure 1. 
 
 Experiential Processes of Change by Stage 
 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance; CR = Consciousness Raising; DR = Dramatic Relief; ER = 
Environmental Reevaluation; SR = Self-reevaluation; SO = Social Liberation. 
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Figure 2. Behavioral Processes of Change by Stage 
 
 Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M 
= Maintenance; SL = Self Liberation; RM = Reinforcement Management; HR = 
Helping Relationships; CC = Counterconditioning; SC = Stimulus Control. 
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APPENDIX A: SUPPLEMENTAL TABLE FOR MANUSCRIPT 1 
Table A1.  
2 x 2 Contingency Table for Reported Chi-Square Test  
 
 
Note. Pre-Action = Precontemplation, Contemplation or Preparation; AM = Action or 
Maintenance. 
 
 
 
    In Treatment
  No Yes
St
ag
e 
Pre-
Action 
38.3% 
(88) 
61.7% 
(142) 
AM  25.8% (94) 
74.2% 
(270) 
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APPENDIX B: SUPPLEMENTAL TABLE FOR MANUSCRIPT 2 
Table B1. 
 
Maximum Likelihood Method Fit Indices for Decisional Balance and Self-Efficacy Confirmatory Models 
 
 χ²(df) CFI GFI RMSEA (CI) 
Decisional Balance     
Model 1: null model 1113.78 (45)* --  -- 
Model 2: uncorrelated two factor model 112.94 (35)* .927 .930 .086 (.068, .103) 
Model 3: correlated two factor model 96.48 (34)* .942 .938 .078 (.060, .096) 
Self-efficacy     
Model 1: null model 862.67 (15) * --  -- 
Model 2: one factor model 37.82(9)* .973 .957 .103 (.070, .137) 
Note. N = 305; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; GFI = Goodness of fit index; RMSEA = root 
mean square error or approximation; CI = confidence interval; *p<0.01 
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APPENDIX C: SUPPLEMENTAL TABLES AND FIGURES FOR MANUSCRIPT 3 
Table C1.  
Maximum Likelihood Method Fit Indices for Processes of Change Confirmatory 
Models 
 
      χ² (df)  CFI RMSEA (CI) 
 
Full null model   11017.91 (435)   --           -- 
 
Ten factor model    1251.74 (360)  0.92  .065 (.061, .068) 
 
Two higher order factor model 1802.76 (394)  0.87   .078 (.074, .081) 
 
 
Note. N= 594; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; 
RMSEA = root mean square error of approximation; CI = confidence interval; *p<.01. 
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Table C2.  
 
Correlations Between Processes of Change 
 
 CR DR ER SR SO CC SC HR RM SL 
CR -- .33 .39 .42 .62 .53 .59 .42 .55 .48 
DR  -- .61 .53 .23 .17 .13 .15 .19 .18 
ER   -- .56 .39 .37 .30 .35 .33 .38 
SR    -- .56 .53 .41 .41 .54 .59 
SO     -- .65 .60 .58 .66 .63 
CC      -- .78 .57 .79 .80 
SC       -- .58 .78 .71 
HR        -- .63 .56 
RM         -- .75 
SL          -- 
Note. CR = Consciousness Raising; DR = Dramatic Relief; ER = Environmental Reevaluation; SR = Self-reevaluation; SO = Social 
Liberation; CC = Counterconditioning; SC = Stimulus Control; HR = Helping Relationships; RM = Reinforcement Management; SL 
= Self Liberation. 
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Figure C1. Two Higher Order Factor Model Diagram 
 
Note. The above diagram illustrates the alternative to the 10-factor fully correlated 
model. In the 10-factor fully correlated model, all POC latent variables were 
correlated. In this model only the disturbances of the two higher order factors were 
correlated (marked by the two way arrow). 
 
 
  
 105 
 
APPENDIX D: TTM CONSRUCTS ACROSS TREATMENT STATUS GROUPS 
 As specified in the above chapters, data was collected on participants’ current 
treatment status. Participants were asked to select one of four mutually exclusive 
categories: (a) I am NOT currently in treatment for anxiety; (b) I currently take 
medication for anxiety (prescribed by a health professional like a doctor, nurse or 
psychiatrist); (c) I currently go to therapy or counseling for anxiety (meeting for 30 
minutes to an hour to discuss your feelings with a professional); (d) I currently take 
medication and go to therapy for anxiety.   
ANOVAs were conducted to evaluate differences in scores on the OASIS and 
continuous TTM constructs (Pros, Cons, Self-efficacy, behavioral Processes of 
Change and experiential Processes of Change) across treatment status group. A chi-
square test was conducted to evaluate the association between Stage of Change and 
treatment status group. 
 Descriptive statistics are summarized in Table D1, ANOVA results are 
summarized in Table D2 below, and the distribution of stage within each treatment 
status group is displayed in Figure D1. A significant difference in level of anxiety 
across treatment status group was observed (F (3, 590) = 13.52, p<.01, η2=.06). Post 
hoc comparisons using the Tukey HSD test indicated that the mean OASIS score of 
participants in combined medication and therapy treatment (M = 13.93, SD = 3.50) 
was significantly higher than that of participants taking medication only (M = 11.69, 
SD = 2.95), in therapy only (M = 12.39, SD = 2.89) and even those not in treatment at 
all (M = 12.02, SD = 3.00). ANOVA also indicated a significant difference in reported 
frequency of behavioral Process of Change use across treatment status group (F(3, 
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590) = 4.31, p < .01, η2=.02). Post hoc comparisons using the Tukey HSD test showed 
that the mean behavioral Process of Change score for those in psychotherapy only (M 
= 46.17, SD = 11.44) was significantly higher than for those not in any treatment (M = 
39.37, SD = 14.59). No other significant group differences were observed. Finally, a 
chi-square test indicated that there was a significant association between stage and 
treatment status group, χ² (12, n= 594) = 25.25, p=.014, phi=.21. 
 The finding that individuals in combined treatment showed the highest level of 
anxiety is counterintuitive, but consistent with existing literature that indicates that 
individuals with higher levels of anxiety tend to seek more treatment than those with 
lower levels of anxiety (Weisberg, Dyck, Culpepper, & Keller, 2007).  
Findings of differences in scores on TTM constructs across treatment status 
groups warrant some discussion. One possible interpretation of the observed 
difference in behavioral Process of Change use is that behavioral Processes of Change 
are encouraged in psychotherapy. Medication, while it may reduce symptoms 
equivalently to psychotherapy, does not entail discussion and problem solving around 
behavior change. The group of individuals engaging in psychotherapy and medication 
reported the most severe symptoms in terms of the OASIS and, therefore, may not 
have been willing to engage in as many behavioral Processes of Change. It is also 
interesting that no other significant differences in TTM variable use across treatment 
status groups were observed. In particular, we would have expected to see similar 
differences in experiential Processes of Change. Reported frequency of experiential 
Process of Change use, however, was high across all treatment status groups. The 
range of mean scores for experiential Processes of Change was 47.62 to 50.57 whereas 
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the range of mean scores for behavioral Processes of Change was 39.37 to 46.17. 
Additionally, while not statistically significant, a similar pattern was observed in 
experiential Process of Change use with those in no treatment reporting the lowest 
level of use and those in psychotherapy only reporting the highest level of use. One 
interpretation of this finding is that experiential Processes of Change around reducing 
avoidance are things that anxious individuals experience naturally (i.e., with or 
without treatment). With regard to other TTM constructs, differences between 
treatment status group mean scores on Pros, Cons and Self-efficacy were small in 
magnitude, which may indicate that more could be done by treatment providers to 
attend to and modify motivational variables. 
Finally, Stage of Change within each treatment status group showed expected 
patterns. Of particular note, was the similarity between the stage profile of those 
taking medication only versus those in psychotherapy only. The main descriptive 
distinction between these two groups was that a higher percentage of those in 
medication only were in Precontemplation than those in therapy only and a higher 
percentage of those in psychotherapy only were in Action. This supports the view that 
it is easier to take medication while not intending to change avoidance patterns than to 
be in psychotherapy while not be intending to change avoidance patterns, since 
medication is by definition a more passive approach to addressing anxiety. Another 
difference of note is the similarity in stage distribution between those not in treatment 
and those in combined treatment. One possible interpretation of this finding is that 
more treatment is not necessarily better in terms of readiness to reduce approach 
behaviors, however this finding may be complicated by the higher level of anxiety 
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observed for those in combined treatment. 
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Table D1. 
Descriptive Statistics for OASIS and TTM Variables by Treatment Status Group 
 
 No 
Treatment 
(n=182) 
Medication 
(n=256) 
Psychotherapy 
(n=54) 
Combined 
(n=102) 
OASIS 12.02 (3.00) 11.67 (2.95) 12.39 (2.89) 13.93 (3.50)
Pros 20.32 (3.97) 20.12 (4.05) 19.78 (3.93) 20.99 (3.65)
Cons 15.68 (4.29) 15.77 (4.21) 16.57 (4.03) 16.66 (4.64)
Self-efficacy 14.85 (4.96) 15.08 (5.13) 15.80 (5.23) 14.24 (5.69)
Exp POC 47.62 (11.33) 47.69 (11.23) 50.57 (10.41) 49.17 (9.02)
Beh POC 39.37 (14.59) 42.23 (12.56) 46.17 (11.44) 40.84 (11.74)
 
Note. Table presents mean scores with standard deviations in parentheses. OASIS = 
Overall Anxiety Severity and Impairment Scale; Exp POC = Experiential Processes of 
Change; Beh POC = Behavioral Processes of Change; Medication = taking medication 
but not psychotherapy for anxiety; Psychotherapy = in psychotherapy but not taking 
medication for anxiety; Combined = taking medication and in psychotherapy for 
anxiety. 
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Table D2. 
 
ANOVAS for OASIS and TTM Variables by Treatment Status Group 
 
DV F P 2 
OASIS 13.52* 0.00 0.064 
Pros 1.52 0.21 0.008 
Cons 1.70 0.17 0.009 
Self-efficacy 1.20 .31 0.006 
Exp POC 1.50 0.21 0.008 
Beh POC 4.31* 0.01 0.021 
 
Note. Between group degrees of freedom for all analyses = 3; Within group degrees of 
freedom for all analyses = 590; OASIS = Overall Anxiety Severity and Impairment 
Scale; Exp POC = Experiential Processes of Change; Beh POC = Behavioral Process 
of Change; df = between group degrees of freedom, within group degrees of freedom; 
*p<.05. 
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Figure D1. 
 
Percentage of Participants in each Stage of Change within Each Treatment Status 
Group 
 
 
 
Note. Medication = taking medication but not psychotherapy for anxiety; 
Psychotherapy = in psychotherapy but not taking medication for anxiety; Combined = 
taking medication and in psychotherapy for anxiety; PC = Precontemplation; C = 
Contemplation; PR = Preparation; A = Action; M = Maintenance.  
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APPENDIX E: DESCRIPTIVE DATA ON REASONS PARTICIPANTS 
ENDORSED FOR NOT SEEKING TREATMENT FOR ANXIETY 
Part of improving the reach of evidence-based treatments for anxiety is 
evaluating why many individuals with clinically significant anxiety are not in 
treatment. Access is one important factor that limits reach, but perceived need and 
other intra-individual factors have also been found to be key reasons individuals do 
not seek treatment (Kivelitz, Watzke, Schulz, Harter, & Melchior, in press; Mojtabai 
et al., 2011; Weisberg et al., 2007). This literature builds a case for the importance of 
interventions and outreach programs that attend to both access and intra-individual 
variables.  
This study sought to examine possible barriers to treatment-seeking by 
providing those not taking medication and/or in psychotherapy for anxiety with a 
checklist of possible reasons for not seeking these treatments. The checklist used was 
adapted from Weisberg et al. (2007). Table E1 presents the frequency with which 
reasons for not taking medication and for not being in psychotherapy were endorsed.  
The most frequent reasons endorsed for not taking medication were concern 
about side effects (52.1%) and the cost of medication (36.4%). The most frequent 
reasons for not engaging in therapy for anxiety were cost (50.0%) and having found 
therapy ineffective in the past (28.1%). Consistent with these findings, financial 
concerns have previously been found to be a prominent reason individuals do not seek 
treatment, especially psychotherapy (Kessler et al., 2001; Mojtabai, Olfson, & 
Mechanic, 2002; Weisberg et al., 2007). Taken together with previous research, these 
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findings indicate that cost-effective, evidence-based behavioral interventions have 
huge potential for reducing impediments to care.  
Interestingly, the least frequent reason endorsed for not taking medication and 
for not seeking therapy was not thinking one had a problem. These findings pose a 
sharp contrast to previous research indicating that low perceived need for treatment is 
a leading reason why many people with clinically significant symptoms do not seek 
mental health treatment. For example, Weisberg et al. (2007) found that in patients 
with anxiety disorders, not thinking they had a problem and not believing in treatment 
for emotional problems were two of the more frequently endorsed reasons for not 
taking medication and for not engaging in psychotherapy. Broader research on reasons 
individuals with mental illness choose not to seek treatment also support not 
recognizing that one has a problem or wanting to solve the problem on their own, as 
prominent factors that distinguish those who seek treatment from those who do not 
(Blumenthal & Endicott, 1998; Kessler et al., 2001; Mojtabai et al., 2011). One 
possible explanation of findings from the present study is that participants in this 
survey were part of a group of individuals interested in participating in health-related 
surveys. It may be that this group is more informed about and open to addressing 
health-related issues. Other studies cited above used proactive recruitment methods, 
which may better capture the full population of individuals with anxiety disorders. 
Nevertheless, this discrepancy in findings calls for further investigation of the degree 
to which individuals with anxiety perceive a need for treatment.  
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Table E1.  
 
Reasons Endorsed for not Receiving Medication (n=236) and Psychotherapy (n=438) for Anxiety 
 
 Reasons for not Receiving Medication Reasons for not Receiving Psychotherapy 
didn’t know how to obtain 14.8% (n=35) 14.6% (n=64) 
financial reasons 36.4% (n=86) 50.0% (n=219) 
worried about sigma/embarrassment 10.6% (n=25) 15.8% (n=69) 
inconvenient/too busy 4.2% (n=10) 19.9% (n=87) 
ineffective in the past 17.8% (n=42) 28.1% (n=123) 
Concerned about side effects 52.1% (n=123) -- 
Didn’t think s/he had a problem 2.5% (n=6) 2.3% (n=10) 
Didn’t believe in medication/therapy 
for emotional problems
14.4% (n=34) 3.4% (n=15) 
Not recommended by doctor 8.1% (n=19) 10.3% (n=45) 
Didn’t think it would help 16.5% (n=39) 19.2% (n=84) 
Concerned about having mental health 
treatment on record
5.9% (n=14) 7.5% (n=33) 
 
Note. Responses provided above were not mutually exclusive. That is, participants could select any options that applied to them. 
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APPENDIX F: CROSS-RACIAL COMPARISONS OF STAGE OF CHANGE AND 
MEAN SCORES ON TTM CONSTRUCTS 
Minority groups are less likely to receive appropriate treatment than 
mainstream populations (U.S. Department of Health and Human Services, 2001). One 
overarching goal of the present program of research is to develop interventions that 
would be accessible to underprivileged groups who are not currently receiving 
appropriate services.  
Based on U.S. Census data, racial minorities constitute approximately 28% of 
the population in the United States (approximately 13% Black/African American, 5% 
Asian, and 1% American Indian/Alaska Native, <1% Native Hawaiian/Other Pacific 
Islander, 9% Other/Mixed race). 2010 U.S. Census data indicate that approximately 
16% of the U.S. population is Hispanic or Latino. The racial distribution of the sample 
in this study approximated US census data. In this sample, 23.6% (n=140) identified 
as a racial minority (12.8% Black/African American, 3.7% Asian, 1.2% American 
Indian/Alaska Native, 0.2% Native Hawaiian/Other Pacific Islander, 5.7% 
Other/Mixed race). Additionally, 14.8% of this sample identified as Hispanic or 
Latino. 
In this early, measurement development, phase of this program of research, 
cross-racial differences were not a focus. Nevertheless, preliminary evaluations of 
differences in TTM constructs and treatment seeking between minority participants 
and non-minority participants were conducted to begin exploring important racial 
factors that may affect measurement and, ultimately, intervention. 
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ANOVA showed significant differences in Cons, Self-efficacy, experiential 
Processes of Change and behavioral Processes of Change between minority and non-
minority participants (Table F1). All differences were in the direction of minority 
participants scoring higher (i.e., greater perceived importance of Cons, higher Self-
efficacy and more frequent use of behavioral and experiential Processes of Change).  
A chi-square test supported association between race and Stage of Change, χ² 
(4, n= 594) = 14.78, p<.01, phi=.16. Descriptive evaluations of percentages of 
minority and nonminority participants in each Stage of Change are displayed in Figure 
F1. The pattern of stage distribution by minority status indicates that the significant 
chi-square may be attributed to the greater percentage of minority participants in 
Action and Maintenance compared to white participants and the greater percentage of 
white participants in Precontemplation and Preparation compared to minority 
participants.  
A chi-square test did not support an association between race and treatment 
seeking in general, χ² (1, n= 594) = 0.05, p=.82, phi=-.01. However, an additional chi-
square test that involved dividing treatment seeking into categories (no treatment, 
medication only, therapy only, and combined) did support an association between race 
and type of treatment χ² (3, n= 594) = 17.97, p<.01, phi=.17. As shown in Figure F2, 
this finding is likely attributable to two trends. First, the percentage of white 
participants taking medication only was higher than the percentage of minority 
participants taking medication only. Second, the percentage of minority participants in 
psychotherapy only or combined (psychotherapy and medication) treatment was 
greater than the percentage of white participants in these treatment categories.  
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These findings indicate that racial differences in use of TTM constructs needs 
to be studied further. Findings may be an artifact of the specific and small sample of 
minority participants recruited in this study. In particular, this study recruited minority 
participants who were part of a national survey company’s database of individuals 
interested in survey research. It is not clear whether this segment of the population in 
is representative of the entire population of individuals with clinically significant 
levels of anxiety for either minorities or non-minorities. Nevertheless, if differences 
hold up in future studies, tailoring algorithms that differ by race (e.g., higher cutoffs 
for tailored feedback) may be important. 
The finding that there was no difference in rates of treatment-seeking between 
minority and non-minority participants is not consistent with predictions based on 
existing literature. Previous research indicates that individuals from minority groups 
are less likely to receive treatment and more likely to report feeling uncomfortable 
talking to a professional about personal problems than non-minorities (Shim, 
Compton, Rust, Druss, & Kaslow, 2009). In contrast to existing research, this study 
evaluated whether treatment was sought and the type of treatment sought rather than 
attitudes toward treatment, which may be a reason findings do not seem to match other 
research to date. Also, again, it is possible that present findings are a result of potential 
sampling bias in the present study driven by use of a survey sampling company for 
recruitment. Nevertheless, further investigation of the nuances of potential differences 
in treatment-seeking across racial categories will be an important area for future 
research.  
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Table F1. 
 
ANOVAS Comparing OASIS and TTM Variables Between White and Minority  
Participants 
 
 
DV 
White  
(n=454)  
M (SD) 
Minority 
(n=140) 
M (SD) 
 
F 
 
p 2 
OASIS 12.13 (3.16) 12.56 (3.13) 1.95 0.16 <0.01 
Pros 20.39 (3.88) 20.02 (4.20) 0.94 0.33 <0.00 
Cons 15.72 (4.23) 16.77 (4.46) 6.50* 0.01 0.01 
Self-efficacy 14.56 (4.91) 16.14 (5.88) 10.05* <.01 0.02 
Exp POC 47.59 (10.53) 50.10 (11.69) 5.76* 0.02 0.01 
Beh POC 40.25 (12.60) 45.45 (13.92) 17.34* <.01 0.03 
 
Note. between group degrees of freedom for all analyses =1;  within group degrees of 
freedom for all analyses = 592; OASIS = Overall Anxiety Severity and Impairment 
Scale; Exp POC = Experiential Processes of Change; Beh POC = Behavioral Process 
of Change; *p<.05. 
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Figure F1. 
Percentage of White and Minority Participants in Each Stage of Change 
 
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M = 
Maintenance.  
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Figure F2. 
 
Percentage of White and Minority Participants in Each Treatment Status Group 
 
Note. Medication = taking medication but not psychotherapy for anxiety; 
Psychotherapy = in psychotherapy but not medication for anxiety; Combined = taking 
medication and in psychotherapy for anxiety.  
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APPENDIX G: CROSS-GENDER COMPARISONS OF STAGE OF CHANGE AND 
MEAN SCORES ON TTM CONSTRUCTS 
Anxiety disorders have been found to be more prevalent in woman then in men 
(Bruce et al., 2005). For example the National Comorbidity survey found that the 
lifetime prevalence of any anxiety disorders was 30.5% in women and 19.2% in men 
(Kessler et al., 2005). Given these prevalence rates, it is not surprising that the sample 
recruited for this study included more women (69.4%, n = 412) than men (30.6%, 
n=182). In this early, measurement development, phase of this program of research, 
gender differences were not a focus. Nevertheless, investigation of differences in 
scores on TTM constructs and treatment-seeking between male and female 
participants were conducted to begin to examine whether gender differences may 
impact measurement and, ultimately, intervention. 
ANOVA showed a significant difference in perceived importance of the Pros 
with women rating perceived importance as significantly higher than men (see Table 
G1). ANOVA also indicated that men reported greater Self-efficacy (that they could 
engage in approach behaviors even in challenging situations) than women (see Table 
G1). It should be noted, that effect sizes of both of these differences were small, so, 
while they are statistically significant, the practical or clinical implications may be 
limited.  
A chi-square test did not support an association between gender and Stage of 
Change, χ² (4, n= 594) = 3.98, p=.41, phi=.08. Similarly, a chi-square test did not 
support an association between gender and treatment status group, χ² (3, n= 594) = 
7.21, p=.065, phi=.11.  
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These findings indicate limited differences across gender. The majority of 
variables evaluated did not show cross-gender differences. Differences that were 
observed had small effect sizes. These results do not, therefore, necessarily indicate 
that different tailoring cutoffs or strategies should be used for males and females. 
Nevertheless, future research with different recruitment methods and longitudinal data 
should continue to evaluate the potential for differences in TTM construct use across 
gender.  
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Table G1. 
ANOVAS Comparing OASIS and TTM Variables Between Male and Female 
Participants 
 
 
DV 
Male 
(n=182)  
M (SD) 
Female 
(n=412) 
M (SD) 
 
F 
 
p 2 
OASIS 12.37 (3.15) 12.18 (3.16)    0.48 0.49 <0.01 
Pros 19.63 (4.02) 20.60 (3.89) 7.81* <0.01 0.01 
Cons 16.46 (4.35) 15.75 (4.27) 3.44 0.06 <0.01 
Self-efficacy 15.84 (5.60) 14.53 (4.95) 8.19* <.01 0.01 
Exp POC 47.33 (10.90) 48.56 (10.83) 1.63 0.20 <0.01 
Beh POC 41.91 (12.46) 41.28 (13.39) 0.29 0.59 <0.01 
 
Note. between group degrees of freedom for all analyses =1; within group degrees of 
freedom for all analyses = 592; M = mean; SD = standard deviation; OASIS = Overall 
Anxiety Severity and Impairment Scale; Exp POC = experiential Processes of Change; 
Beh POC = behavioral Process of Change; *p<.05. 
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